0001777921 AvePoint, Inc. false --12-31 Q1 2025 0.0001 0.0001 1,000,000 1,000,000 203,031 203,031 194,071 194,071 12 http://fasb.org/us-gaap/2025#SecuredOvernightFinancingRateSofrMember 3 3 5 4 203,030,980 194,070,512 3 1 0 4 10 4 14.66 8.19 193,477 191,044 1 11.6 false false false December 18, 2024 Brian Michael Brown Chief Legal and Compliance Officer, and Secretary true December 18, 2025 The other segment items category includes professional services, rent, software maintenance, travel, depreciation and amortization, certain overhead expense, and mark-to-market of earn-out shares liabilities and warrant liabilities. Refer to “Note 11 — Warrant Liabilities” for further details. Include long-term unbilled receivables. Profits on securities consist of interest income from amortization of the discount arising at acquisition of U.S. treasury bills. The fair value of mandatorily redeemable noncontrolling interest is based on discounted redemption value using risk-free rates offered for similar financing with the same remaining maturities. Variable lease cost includes common area maintenance, property taxes, and fluctuations in rent due to a change in an index or rate. The majority of certificates of deposit are foreign deposits. Includes the current portion of operating lease liabilities of $5.9 million, which is reflected in accrued expenses and other liabilities in the condensed consolidated balance sheets. Short-term lease expenses include rent expenses from leases of 12 months or less on the transition date or lease commencement. During 2023, the Company extended a credit facility to LCP with a total commitment of up to $5.0 million and maturities of greater than twelve months (the “LCP Notes Receivable”). Refer to “Note 13 — Growth Equity Fund” for further details. The LCP Notes Receivable bear interest at an annual rate equal to 8%. As of March 31, 2025 and December 31, 2024, the LCP Notes Receivable in the amounts of $3.9 million and $3.8 million, respectively, were included in other assets within the condensed consolidated balance sheets. Fair values are based on discounted future cash flows using current interest rates offered for similar notes to third parties with similar credit ratings for the same remaining maturities. 00017779212025-01-012025-03-31 0001777921us-gaap:CommonStockMember2025-01-012025-03-31 0001777921us-gaap:WarrantMember2025-01-012025-03-31 xbrli:shares 00017779212025-05-07 thunderdome:item iso4217:USD 00017779212025-03-31 00017779212024-12-31 iso4217:USDxbrli:shares 0001777921avpt:SAASMember2025-01-012025-03-31 0001777921avpt:SAASMember2024-01-012024-03-31 0001777921avpt:TermedLicenseAndSupportMember2025-01-012025-03-31 0001777921avpt:TermedLicenseAndSupportMember2024-01-012024-03-31 0001777921us-gaap:ServiceMember2025-01-012025-03-31 0001777921us-gaap:ServiceMember2024-01-012024-03-31 0001777921us-gaap:MaintenanceMember2025-01-012025-03-31 0001777921us-gaap:MaintenanceMember2024-01-012024-03-31 00017779212024-01-012024-03-31 0001777921us-gaap:CommonStockMember2024-12-31 0001777921us-gaap:AdditionalPaidInCapitalMember2024-12-31 0001777921us-gaap:RetainedEarningsMember2024-12-31 0001777921us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-31 0001777921us-gaap:NoncontrollingInterestMember2024-12-31 0001777921us-gaap:CommonStockMember2025-01-012025-03-31 0001777921us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-31 0001777921us-gaap:RetainedEarningsMember2025-01-012025-03-31 0001777921us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-31 0001777921us-gaap:NoncontrollingInterestMember2025-01-012025-03-31 0001777921us-gaap:CommonStockMember2025-03-31 0001777921us-gaap:AdditionalPaidInCapitalMember2025-03-31 0001777921us-gaap:RetainedEarningsMember2025-03-31 0001777921us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-31 0001777921us-gaap:NoncontrollingInterestMember2025-03-31 0001777921us-gaap:NoncontrollingInterestMember2023-12-31 0001777921avpt:TemporaryEquityIncludingPortionAttributableToNoncontrollingInterestsMember2023-12-31 0001777921us-gaap:CommonStockMember2023-12-31 0001777921us-gaap:AdditionalPaidInCapitalMember2023-12-31 0001777921us-gaap:RetainedEarningsMember2023-12-31 0001777921us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-31 00017779212023-12-31 0001777921us-gaap:CommonStockMember2024-01-012024-03-31 0001777921us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-31 0001777921us-gaap:RetainedEarningsMember2024-01-012024-03-31 0001777921us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-31 0001777921us-gaap:NoncontrollingInterestMember2024-01-012024-03-31 0001777921avpt:TemporaryEquityIncludingPortionAttributableToNoncontrollingInterestsMember2024-01-012024-03-31 0001777921us-gaap:NoncontrollingInterestMember2024-01-012024-12-31 0001777921avpt:TemporaryEquityIncludingPortionAttributableToNoncontrollingInterestsMember2024-01-012024-12-31 0001777921us-gaap:NoncontrollingInterestMember2024-03-31 0001777921avpt:TemporaryEquityIncludingPortionAttributableToNoncontrollingInterestsMember2024-03-31 0001777921us-gaap:CommonStockMember2024-03-31 0001777921us-gaap:AdditionalPaidInCapitalMember2024-03-31 0001777921us-gaap:RetainedEarningsMember2024-03-31 0001777921us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-31 00017779212024-03-31 0001777921avpt:TermedLicenseAndSupportMemberus-gaap:TransferredAtPointInTimeMember2025-01-012025-03-31 0001777921avpt:TermedLicenseAndSupportMemberus-gaap:TransferredAtPointInTimeMember2024-01-012024-03-31 0001777921avpt:SAASMember2025-03-31 xbrli:pure 00017779212025-04-012025-03-31 utr:M 0001777921avpt:YdenticHoldingBvMember2025-01-29 0001777921avpt:YdenticHoldingBvMemberavpt:YdenticBVMember2025-01-29 0001777921avpt:YdenticHoldingBvMember2025-01-292025-01-29 0001777921avpt:YdenticHoldingBvMemberavpt:SharesSubjectToMandatoryRedemptionMember2025-01-292025-01-29 0001777921avpt:YdenticHoldingBvMember2025-01-012025-03-31 0001777921avpt:YdenticHoldingBvMemberus-gaap:TechnologyBasedIntangibleAssetsMember2025-01-292025-01-29 utr:Y 0001777921avpt:YdenticHoldingBvMemberus-gaap:CustomerRelatedIntangibleAssetsMember2025-01-292025-01-29 0001777921avpt:YdenticHoldingBvMemberavpt:SharesSubjectToMandatoryRedemptionMember2025-01-29 0001777921avpt:YdenticHoldingBvMemberavpt:SharesSubjectToMandatoryRedemptionMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-01-29 0001777921avpt:YdenticHoldingBvMemberavpt:SharesSubjectToMandatoryRedemptionMember2025-03-31 0001777921us-gaap:TechnologyBasedIntangibleAssetsMember2025-03-31 0001777921us-gaap:TechnologyBasedIntangibleAssetsMember2024-12-31 0001777921us-gaap:CustomerRelationshipsMember2025-03-31 0001777921us-gaap:CustomerRelationshipsMember2024-12-31 0001777921us-gaap:MediaContentMember2025-03-31 0001777921us-gaap:MediaContentMember2024-12-31 0001777921us-gaap:TradeAccountsReceivableMember2025-03-31 0001777921us-gaap:TradeAccountsReceivableMember2024-12-31 0001777921avpt:UnbilledReceivableMember2025-03-31 0001777921avpt:UnbilledReceivableMember2024-12-31 0001777921us-gaap:RevolvingCreditFacilityMemberavpt:HSBCVentureBankUsaIncMember2023-11-03 0001777921avpt:LineOfCreditAccordionFeatureMemberavpt:HSBCVentureBankUsaIncMember2023-11-03 00017779212023-11-032023-11-03 0001777921avpt:LineOfCreditAccordionFeatureMemberavpt:HSBCVentureBankUsaIncMembersrt:MinimumMember2023-11-032023-11-03 0001777921avpt:LineOfCreditAccordionFeatureMemberavpt:HSBCVentureBankUsaIncMembersrt:MaximumMember2023-11-032023-11-03 0001777921avpt:LineOfCreditAccordionFeatureMemberavpt:HSBCVentureBankUsaIncMember2023-11-032023-11-03 0001777921us-gaap:RevolvingCreditFacilityMemberavpt:HSBCVentureBankUsaIncMember2025-03-31 0001777921avpt:GuaranteeForServiceAgreementMember2022-12-31 0001777921avpt:ITSolutionsMember2022-12-012022-12-31 0001777921avpt:ITSolutionsMember2025-01-012025-03-31 0001777921avpt:ITSolutionsMember2024-01-012024-03-31 0001777921avpt:ITSolutionsMember2024-12-31 0001777921avpt:ITSolutionsMember2024-12-012024-12-31 0001777921avpt:GrowthEquityFundMember2024-02-28 0001777921avpt:ClassActionLawsuitMemberavpt:DefendantsMember2024-02-022024-02-02 0001777921avpt:ClassActionLawsuitMemberavpt:SponsorsMember2024-02-022024-02-02 0001777921avpt:ClassActionLawsuitMember2024-01-012024-12-31 0001777921avpt:ClassActionLawsuitMember2024-10-012024-10-31 0001777921avpt:AccruedExpenseAndOtherCurrentLiabilitiesMemberavpt:ClassActionLawsuitMember2024-12-31 0001777921avpt:GuaranteeForServiceAgreementMember2025-03-31 0001777921avpt:PrivatePlacementWarrantMember2021-07-01 0001777921avpt:PrivatePlacementWarrantMember2025-03-31 0001777921avpt:PrivatePlacementWarrantMember2024-12-31 0001777921avpt:PrivatePlacementWarrantMember2025-01-012025-03-31 0001777921avpt:PrivatePlacementWarrantMember2024-01-012024-03-31 00017779212022-03-172022-03-17 00017779212022-02-25 0001777921avpt:PublicWarrantMember2021-07-01 0001777921avpt:PublicWarrantMember2025-01-012025-03-31 0001777921avpt:PublicWarrantMember2025-03-31 0001777921avpt:A3VenturesFund1LpMember2024-02-282024-02-28 0001777921avpt:A3VenturesFund1LpMember2024-02-28 0001777921avpt:A3VenturesFund1LpMember2025-01-012025-03-31 0001777921avpt:A3VenturesFund1LpMember2025-03-31 0001777921avpt:A3VenturesFund1LpMember2024-12-31 0001777921avpt:A3VenturesFund1LpMember2024-01-012024-03-31 0001777921avpt:The2021PlanMember2025-03-31 0001777921avpt:The2021PlanMember2025-01-012025-03-31 0001777921avpt:The2021PlanMember2024-01-012024-03-31 0001777921us-gaap:EmployeeStockOptionMemberavpt:The2021PlanMember2025-01-012025-03-31 0001777921avpt:The2021PlanMember2025-03-142025-03-14 0001777921us-gaap:RestrictedStockUnitsRSUMemberavpt:The2021PlanMember2024-01-012024-06-30 0001777921us-gaap:RestrictedStockUnitsRSUMemberavpt:The2021PlanMember2025-01-012025-03-31 0001777921us-gaap:PerformanceSharesMemberavpt:The2021PlanMember2025-01-012025-03-31 0001777921us-gaap:RestrictedStockUnitsRSUMemberavpt:The2021PlanMember2025-03-31 0001777921us-gaap:PerformanceSharesMemberavpt:The2021PlanMember2025-03-31 0001777921us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2025-03-31 0001777921us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel2Member2025-03-31 0001777921us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel3Member2025-03-31 0001777921us-gaap:CertificatesOfDepositMember2025-03-31 0001777921us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2025-03-31 0001777921us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2025-03-31 0001777921us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2025-03-31 0001777921us-gaap:MoneyMarketFundsMember2025-03-31 0001777921us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-03-31 0001777921us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-03-31 0001777921us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-03-31 0001777921us-gaap:USTreasurySecuritiesMember2025-03-31 0001777921us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2025-03-31 0001777921us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel2Member2025-03-31 0001777921us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel3Member2025-03-31 0001777921us-gaap:NotesReceivableMember2025-03-31 0001777921us-gaap:FairValueInputsLevel1Member2025-03-31 0001777921us-gaap:FairValueInputsLevel2Member2025-03-31 0001777921us-gaap:FairValueInputsLevel3Member2025-03-31 0001777921us-gaap:FairValueInputsLevel1Memberavpt:UnconditionalPurchaseObligationMember2025-03-31 0001777921us-gaap:FairValueInputsLevel2Memberavpt:UnconditionalPurchaseObligationMember2025-03-31 0001777921us-gaap:FairValueInputsLevel3Memberavpt:UnconditionalPurchaseObligationMember2025-03-31 0001777921avpt:UnconditionalPurchaseObligationMember2025-03-31 0001777921us-gaap:FairValueInputsLevel1Memberavpt:WarrantLiabilitiesMember2025-03-31 0001777921us-gaap:FairValueInputsLevel2Memberavpt:WarrantLiabilitiesMember2025-03-31 0001777921us-gaap:FairValueInputsLevel3Memberavpt:WarrantLiabilitiesMember2025-03-31 0001777921avpt:WarrantLiabilitiesMember2025-03-31 0001777921us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2024-12-31 0001777921us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel2Member2024-12-31 0001777921us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel3Member2024-12-31 0001777921us-gaap:CertificatesOfDepositMember2024-12-31 0001777921us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2024-12-31 0001777921us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2024-12-31 0001777921us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2024-12-31 0001777921us-gaap:MoneyMarketFundsMember2024-12-31 0001777921us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-12-31 0001777921us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel2Member2024-12-31 0001777921us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-12-31 0001777921us-gaap:USTreasurySecuritiesMember2024-12-31 0001777921us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2024-12-31 0001777921us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel2Member2024-12-31 0001777921us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel3Member2024-12-31 0001777921us-gaap:NotesReceivableMember2024-12-31 0001777921us-gaap:FairValueInputsLevel1Member2024-12-31 0001777921us-gaap:FairValueInputsLevel2Member2024-12-31 0001777921us-gaap:FairValueInputsLevel3Member2024-12-31 0001777921us-gaap:FairValueInputsLevel1Memberavpt:WarrantLiabilitiesMember2024-12-31 0001777921us-gaap:FairValueInputsLevel2Memberavpt:WarrantLiabilitiesMember2024-12-31 0001777921us-gaap:FairValueInputsLevel3Memberavpt:WarrantLiabilitiesMember2024-12-31 0001777921avpt:WarrantLiabilitiesMember2024-12-31 0001777921avpt:LumensCapitalPartnersLtdTheLcpMember2023-12-31 0001777921avpt:LumensCapitalPartnersLtdTheLcpMember2025-03-31 0001777921avpt:LumensCapitalPartnersLtdTheLcpMember2024-12-31 0001777921us-gaap:USTreasurySecuritiesMember2025-03-31 0001777921us-gaap:USTreasurySecuritiesMember2024-12-31 0001777921srt:NorthAmericaMember2025-01-012025-03-31 0001777921srt:NorthAmericaMember2024-01-012024-03-31 0001777921us-gaap:EMEAMember2025-01-012025-03-31 0001777921us-gaap:EMEAMember2024-01-012024-03-31 0001777921srt:AsiaPacificMember2025-01-012025-03-31 0001777921srt:AsiaPacificMember2024-01-012024-03-31 0001777921country:US2025-01-012025-03-31 0001777921country:US2024-01-012024-03-31 0001777921country:DE2025-01-012025-03-31 0001777921country:DE2024-01-012024-03-31 0001777921country:SG2025-01-012025-03-31 0001777921country:SG2024-01-012024-03-31 0001777921us-gaap:EmployeeStockOptionMember2025-01-012025-03-31 0001777921us-gaap:EmployeeStockOptionMember2024-01-012024-03-31 0001777921us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-31 0001777921us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-31 0001777921us-gaap:WarrantMember2025-01-012025-03-31 0001777921us-gaap:WarrantMember2024-01-012024-03-31 0001777921us-gaap:EmployeeStockOptionMember2025-01-012025-03-31 0001777921us-gaap:EmployeeStockOptionMember2024-01-012024-03-31 0001777921us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-31 0001777921us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-31 0001777921us-gaap:WarrantMember2025-01-012025-03-31 0001777921us-gaap:WarrantMember2024-01-012024-03-31 0001777921avpt:CompanyEarnOutsMember2025-01-012025-03-31 0001777921avpt:CompanyEarnOutsMember2024-01-012024-03-31 0001777921avpt:MaivenpointPtdLtdMemberus-gaap:SubsequentEventMember2025-04-012025-04-30
 

 

Table of Contents



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2025

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to ___________.

 

Commission file number: 001-39048

 

AvePoint, Inc.


(Exact name of registrant as specified in its charter)

 

Delaware

83-4461709

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

525 Washington Blvd, Suite 1400

Jersey City, NJ 07310

(Address of principal executive offices) (Zip Code)

 

(804) 314-5903

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report).

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading symbol

 

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

AVPT

 

The Nasdaq Global Select Market

Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share

 

AVPTW

 

The Nasdaq Global Select Market

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer ☐

Non-accelerated filer ☐Smaller reporting company
 Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☒

 

As of May 7, 2025, there were 203,233,202 shares of the registrant’s common stock, par value $0.0001 per share, issued and outstanding.

 



 

 

 

 

AVEPOINT, INC.

FORM 10-Q

For the Fiscal Quarter Ended March 31, 2025

TABLE OF CONTENTS

 

  Page
FORWARD-LOOKING STATEMENTS 3

PART I. FINANCIAL INFORMATION

4

Item 1. Financial Statements

4

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

30

Item 3. Quantitative and Qualitative Disclosures About Market Risk

43

Item 4. Controls and Procedures

44

PART II. OTHER INFORMATION

45

Item 1. Legal Proceedings

45

Item 1A. Risk Factors

45

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities  46
Item 3. Defaults Upon Senior Securities 46
Item 4. Mine Safety Disclosures 46
Item 5. Other Information 47

Item 6. Exhibits

48

Signatures 49

 

2

 

 

FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “Quarterly Report”) of AvePoint, Inc. (hereinafter referred to as the “Company,” “AvePoint,” “we," “us” and “our”) includes estimates, projections, statements relating to our business plans, objectives, and expected operating results that may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements, as well as descriptions of the risks and uncertainties that could cause actual results and events to differ materially, may appear throughout this Quarterly Report, including in the following sections: “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (Part I, Item 2 of this Quarterly Report), “Quantitative and Qualitative Disclosures about Market Risk” (Part I, Item 3 of this Quarterly Report), and “Risk Factors” (Part II, Item 1A of this Quarterly Report). These risks and uncertainties also include, but are not limited to, those described from time to time in the Company’s reports filed with the Securities and Exchange Commission (“SEC”).

 

These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. All statements that address operating performance, events, or developments that we expect or anticipate will occur in the future — including statements relating to volume growth, sales, earnings, and statements expressing general views about future operating results — are forward-looking statements. These forward-looking statements are, by their nature, subject to significant risks and uncertainties, and are based on the beliefs of, as well as assumptions made by and information currently available to, our management. Our management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. Readers should evaluate all forward-looking statements made in the context of these risks and uncertainties. The important factors referenced above may not contain all of the factors that are important to investors.

 

In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our operations in the way we expect. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise, except as required by law. All written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by these cautionary statements as well as other cautionary statements that are made from time to time in our other SEC filings and public communications.

 

3

PART I

Item 1

 

PART I. FINANCIAL INFORMATION.

 

Item 1. Financial Statements.

 

 

Index to Financial Statements (Unaudited)

 

Page

Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024   5
Condensed Consolidated Statements of Income (Loss) for the Three Months Ended March 31, 2025 and 2024   6
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months Ended March 31, 2025 and 2024   7
Condensed Consolidated Statements of Mezzanine Equity and Stockholders’ Equity for the Three Months Ended March 31, 2025 and 2024   8
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 2024   9
Notes to Condensed Consolidated Financial Statements   10

 

4

 

 

AvePoint, Inc.

Condensed Consolidated Balance Sheets

(In thousands, except par value)

(Unaudited)

 

  

March 31,

  

December 31,

 
  

2025

  

2024

 

Assets

        

Current assets:

        

Cash and cash equivalents

 $351,481  $290,735 

Short-term investments

  317   167 

Accounts receivable, net

  80,124   87,365 

Prepaid expenses and other current assets

  14,717   16,528 

Total current assets

  446,639   394,795 

Property and equipment, net

  5,961   5,289 

Goodwill

  36,774   17,715 

Intangible assets, net

  11,514   8,889 

Operating lease right-of-use assets

  17,813   15,954 

Deferred contract costs

  59,945   59,838 

Other assets

  20,202   16,575 

Total assets

 $598,848  $519,055 

Liabilities and stockholders’ equity

        

Current liabilities:

        

Accounts payable

 $2,293  $2,352 

Accrued expenses and other current liabilities

  56,154   76,135 

Current portion of deferred revenue

  149,760   144,468 

Total current liabilities

  208,207   222,955 

Long-term operating lease liabilities

  11,649   9,909 

Long-term portion of deferred revenue

  10,846   8,840 

Other liabilities

  6,693   6,403 

Total liabilities

  237,395   248,107 

Commitments and contingencies (Note 10)

          

Stockholders’ equity

        

Common stock, $0.0001 par value; 1,000,000 shares authorized, 203,031 and 194,071 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively

  20   19 

Additional paid-in capital

  873,269   779,007 

Accumulated other comprehensive income

  1,682   576 

Accumulated deficit

  (515,468)  (510,448)

Noncontrolling interest

  1,950   1,794 

Total stockholders’ equity

  361,453   270,948 

Total liabilities and stockholders’ equity

 $598,848  $519,055 

 

See accompanying notes.

 

5

 

 

AvePoint, Inc.

Condensed Consolidated Statements of Income (Loss)

(In thousands, except per share amounts)

(Unaudited)

 

   

Three Months Ended

 
   

March 31,

 
   

2025

   

2024

 

Revenue:

               

SaaS

  $ 68,942     $ 51,311  

Term license and support

    11,190       10,005  

Services

    10,937       10,481  

Maintenance

    1,995       2,737  

Total revenue

    93,064       74,534  

Cost of revenue:

               

SaaS

    12,537       9,770  

Term license and support

    411       416  

Services

    10,798       10,073  

Maintenance

    153       183  

Total cost of revenue

    23,899       20,442  

Gross profit

    69,165       54,092  

Operating expenses:

               

Sales and marketing

    34,522       29,939  

General and administrative

    18,667       16,868  

Research and development

    12,689       10,486  

Total operating expenses

    65,878       57,293  

Income (loss) from operations

    3,287       (3,201 )

Other income, net

    1,586       3,404  

Income before income taxes

    4,873       203  

Income tax expense

    1,307       2,157  

Net income (loss)

  $ 3,566     $ (1,954 )

Net income (loss) attributable to noncontrolling interest

    126       (238 )

Net income (loss) available to common stockholders

  $ 3,440     $ (1,716 )

Net income (loss) per share:

               

Basic

  $ 0.02     $ (0.01 )

Diluted

  $ 0.02     $ (0.01 )

Weighted average shares outstanding:

               

Basic

    197,924       181,495  

Diluted

    224,573       181,495  

 

See accompanying notes.

 

6

 

 

AvePoint, Inc.

Condensed Consolidated Statements of Comprehensive Income (Loss)

(In thousands)

(Unaudited)

 

   

Three Months Ended

 
   

March 31,

 
   

2025

   

2024

 

Net income (loss)

  $ 3,566     $ (1,954 )

Other comprehensive income (loss) net of taxes

               

Unrealized loss on available-for-sale securities

    (12 )     (100 )

Foreign currency translation adjustments

    1,148       (478 )

Total other comprehensive income (loss)

    1,136       (578 )

Total comprehensive income (loss)

  $ 4,702     $ (2,532 )

Comprehensive income (loss) attributable to noncontrolling interest

    156       (311 )

Total comprehensive income (loss) available to common stockholders

  $ 4,546     $ (2,221 )

 

See accompanying notes.

 

7

 

 

AvePoint, Inc.

Condensed Consolidated Statements of Mezzanine Equity and Stockholders’ Equity

(In thousands, except share amounts)

(Unaudited)

 

   

Three Months Ended March 31, 2025

 
                                   

Accumulated

                 
                   

Additional

           

Other

           

Total

 
   

Common Stock

   

Paid-In

   

Accumulated

   

Comprehensive

   

Noncontrolling

   

Stockholders’

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Interest

   

Equity

 

Balance, December 31, 2024

    194,070,512     $ 19     $ 779,007     $ (510,448 )   $ 576     $ 1,794     $ 270,948  

Proceeds from exercise of options

    418,369             744                         744  

Common stock issued upon vesting of restricted stock units

    1,747,995                                      

Stock-based compensation expense

                9,620                         9,620  

Proceeds from exercise of warrants

    7,595,099       1       87,343                         87,344  

Repurchase and retirement of common stock

    (800,995 )           (3,445 )     (8,460 )                 (11,905 )

Comprehensive income:

                                                       

Net income

                      3,440             126       3,566  

Unrealized loss on available-for-sale securities

                            (12 )           (12 )

Foreign currency translation adjustments

                            1,118       30       1,148  

Balance, March 31, 2025

    203,030,980     $ 20     $ 873,269     $ (515,468 )   $ 1,682     $ 1,950     $ 361,453  

 

   

Three Months Ended March 31, 2024

 
   

Redeemable

   

Total

                                   

Accumulated

                 
   

noncontrolling

   

mezzanine

                   

Additional

           

Other

           

Total

 
   

interest

   

equity

   

Common Stock

   

Paid-In

   

Accumulated

   

Comprehensive

   

Noncontrolling

   

Stockholders’

 
   

Amount

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Interest

   

Equity

 

Balance, December 31, 2023

  $ 6,038     $ 6,038       184,652,402     $ 18     $ 667,881     $ (460,496 )   $ 3,196     $ 8,207     $ 218,806  

Proceeds from exercise of options

                293,361             784                         784  

Common stock issued upon vesting of restricted stock units

                2,028,720       1       (1 )                        

Stock-based compensation expense

                            9,458                         9,458  

Accretion of redeemable noncontrolling interest

    (99 )     (99 )                       99                   99  

Redemption of noncontrolling interest

    (5,926 )     (5,926 )                 6,379             2       (6,381 )      

Reclassification of earn-out RSUs to earn-out shares

                            (137 )                       (137 )

Repurchase and retirement of common stock

                (1,758,850 )           (6,438 )     (7,305 )                 (13,743 )

Comprehensive loss:

                                                                       

Net loss

    (5 )     (5 )                       (1,815 )           (134 )     (1,949 )

Unrealized loss on available-for-sale securities

                                        (100 )           (100 )

Foreign currency translation adjustments

    (8 )     (8 )                             (405 )     (65 )     (470 )

Balance, March 31, 2024

  $     $       185,215,633     $ 19     $ 677,926     $ (469,517 )   $ 2,693     $ 1,627     $ 212,748  

 

See accompanying notes.

 

8

 

 

AvePoint, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

   

Three Months Ended

 
   

March 31,

 
   

2025

   

2024

 

Operating activities

               

Net income (loss)

  $ 3,566     $ (1,954 )

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

               

Depreciation and amortization

    1,511       1,295  

Operating lease right-of-use assets expense

    1,847       1,420  

Foreign currency remeasurement loss

    540       580  

Stock-based compensation

    9,620       9,458  

Deferred income taxes

    (95 )     (72 )

Other

    1,064       (146 )

Change in value of earn-out and warrant liabilities

    (474 )     (1,490 )

Changes in operating assets and liabilities:

               

Accounts receivable

    9,198       10,933  

Prepaid expenses and other current assets

    1,895       1,718  

Deferred contract costs and other assets

    (2,637 )     4,447  

Accounts payable, accrued expenses, other current liabilities, operating lease liabilities and other liabilities

    (29,751 )     (14,293 )

Deferred revenue

    4,211       (4,140 )

Net cash provided by operating activities

    495       7,756  

Investing activities

               

Maturities of investments

          240  

Purchases of investments

          (389 )

Capitalization of internal-use software

    (452 )     (391 )

Purchase of property and equipment

    (1,514 )     (502 )

Issuance of notes receivables

          (500 )

Cash paid in business combinations, net of cash acquired

    (14,893 )      

Net cash used in investing activities

    (16,859 )     (1,542 )

Financing activities

               

Purchase of common stock

    (11,905 )     (13,743 )

Proceeds from warrant exercises

    87,344        

Proceeds from stock option exercises

    744       784  

Repayments of finance leases

    (2 )     (2 )

Net cash provided by (used in) financing activities

    76,181       (12,961 )

Effect of exchange rates on cash

    929       (926 )

Net increase (decrease) in cash and cash equivalents

    60,746       (7,673 )

Cash and cash equivalents at beginning of period

    290,735       223,162  

Cash and cash equivalents at end of period

  $ 351,481     $ 215,489  

Supplemental disclosures of cash flow information

               

Income taxes paid

  $ 901     $ 984  

Unpaid purchase consideration transferred in connection with the business combination

  $ 5,499     $  

Unpaid redemption of noncontrolling interest

  $     $ 5,926  

 

See accompanying notes.

 

  

9

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)

 

1. Nature of Business and Organization

 

AvePoint, Inc. (collectively with its subsidiaries, hereinafter referred to as “AvePoint,” the “Company,” “we,” “us,” or “our”) was incorporated as a New Jersey corporation on July 24, 2001 and redomiciled as a Delaware corporation in 2006.

 

Our principal executive headquarters is located in Jersey City, New Jersey, and our principal operating headquarters is located in Richmond, Virginia. We have additional offices in North America, Europe, Asia, Australia and the Middle East.

 

AvePoint generates revenue by providing customers a cloud-native data management software platform (the “AvePoint Confidence Platform”), enabling them to prepare, secure, and optimize their critical data. The AvePoint Confidence Platform unifies data security, governance, and business continuity into a seamless, resilient experience, addressing the most pressing challenges in today’s complex digital landscape.

 

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated balance sheet as of December 31, 2024, which has been derived from audited financial statements, and the unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information and include the accounts of the Company and entities consolidated under the variable interest and voting models. All intercompany transactions and balances have been eliminated. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the U.S. (“GAAP”) have been condensed or omitted.

 

In the opinion of management, these financial statements contain all material adjustments, consisting of normal recurring accruals, necessary to present fairly the financial position, results of operations and cash flows for the periods indicated. Operating results for the three months ended March 31, 2025 are not necessarily indicative of the results that may be expected for any other interim period or for the year ended December 31, 2025.

 

These condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the related notes included in our most recent Annual Report on Form 10-K for the year ended  December 31, 2024, which was filed with the SEC on February 27, 2025 (“Annual Report”).


 

10

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 

Use of Estimates

 

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. We base our estimates and assumptions on historical experience and on various other assumptions that we believe are reasonable under the circumstances. The amounts of assets and liabilities reported and the amounts of revenue and expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, the accounting for the determination of standalone selling price for revenue recognition, deferred contract costs, valuation of goodwill and other intangible assets, income taxes and related reserves, stock-based compensation and purchase price in a business combination. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties.

 

Cash and Cash Equivalents

 

The Company maintains cash and cash equivalents with several high credit-quality financial institutions. The Company considers its investments with original maturities of three months or less to be cash equivalents. These investments are not subject to significant market risk. The Company maintains its cash and cash equivalents in bank accounts which, at times, exceed the federally insured limits. The Company has not experienced any losses in such accounts. The Company maintains cash balances used in operations at entities based in countries that impose regulations that limit the ability to transfer cash out of the country. As of March 31, 2025 and December 31, 2024, the Company’s cash balances at these entities were $12.3 million and $15.5 million, respectively. For purposes of the condensed consolidated statements of cash flows, cash includes all amounts in the condensed consolidated balance sheets captioned cash and cash equivalents.

 

Business Combination

 

When we consummate a business combination, the assets acquired, and the liabilities assumed are recognized separately from goodwill at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of the fair value of consideration transferred over the acquisition date fair value of the net identifiable assets acquired. While best estimates and assumptions are used to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which  may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill as we obtain new information about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. Upon the earlier of the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, any subsequent adjustments are recorded in the condensed consolidated statements of income (loss).

 

11

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 

Goodwill

 

No events or circumstances have changed since any of our acquisitions that would indicate that the fair value of our reporting unit is below its carrying amount. No impairment was deemed necessary as of March 31, 2025 or  December 31, 2024.

 

Deferred Contract Costs

 

We defer sales commissions that are considered to be incremental and recoverable costs of obtaining or renewing SaaS, term license and support, services, and maintenance contracts. Changes in the anticipated period of asset benefit or the average renewal term are recognized on a prospective basis upon occurrence. 

 

Amortization of deferred contract costs of $5.5 million for the three months ended March 31, 2025, and $5.3 million for the three months ended  March 31, 2024, is included as a component of sales and marketing expenses in our condensed consolidated statements of income (loss). Deferred contract costs recognized as a contract asset in the condensed consolidated balance sheets were $59.9 million and $59.8 million as of  March 31, 2025 and December 31, 2024, respectively.

 

Revenue Recognition

 

The Company derives revenue from four primary sources: SaaS, term license and support, services, and maintenance. Services include installation services, training and other consulting services.

 

Term license revenue recognized at a point in time was $7.2 million for the three months ended March 31, 2025, and $5.6 million for the three months ended  March 31, 2024.

 

Accounts receivable, net is inclusive of accounts receivable, and current unbilled receivables, net of allowance for credit losses. We record an unbilled receivable when revenue is recognized prior to invoicing. We have a well-established collection history from our direct and indirect sales. We periodically evaluate the collectability of our accounts receivable and provide an allowance for credit losses as necessary, based on the age of the receivable, expected payment ability, and collection experience. As of March 31, 2025 and December 31, 2024, the allowance for credit losses was not material.

 

We record deferred revenue in the condensed consolidated balance sheets when cash is collected or invoiced before revenue is earned. Deferred revenue as of March 31, 2025 and December 31, 2024 was $160.6 million and $153.3 million, respectively. Revenue recognized that was included in the deferred revenue balance at the beginning of the period was $57.4 million for the three months ended March 31, 2025.

 

12

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 

The opening and closing balances of the Company’s accounts receivable, net, deferred revenue and deferred contract costs are as follows:

 

  

Accounts

      

Deferred

 
  

receivable,

  

Deferred

  

contract

 
  

net (1)

  

revenue

  

costs

 
  

(in thousands)

 

Balance, December 31, 2024

 $95,683  $153,308  $59,838 

Balance, March 31, 2025

  90,066   160,606   59,945 

 

(1) Includes long-term unbilled receivables. 

 

There were no significant changes to the Company’s contract assets or liabilities during the three months ended March 31, 2025 and the year ended December 31, 2024 outside of its sales activities.

 

As of March 31, 2025, transaction price allocated to remaining performance obligations, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods, was $405.1 million, of which $337.7 million is related to SaaS and term license and support revenue. We expect to recognize approximately 62% of the total transaction price allocated to remaining performance obligations over the next twelve months and the remainder thereafter.

 

Stock-Based Compensation

 

Stock-based compensation represents the cost related to stock-based awards granted to employees. To date, we have issued both stock options and restricted stock units. The Company measures stock-based compensation cost at the grant date based on the estimated fair value of the award and recognizes the cost ratably over the requisite service period, net of actual forfeitures in the period.

 

We estimate the fair value of stock options using the Black-Scholes valuation model. The Black-Scholes model requires highly subjective assumptions in order to derive the inputs necessary to calculate the fair value of stock options. To estimate the expected term of stock options, the Company considers contractual terms of the options, including the vesting and expiration periods, as well as historical option exercise data and current market conditions to determine an estimated expected term. The Company’s historical experience is too limited to be able to reasonably estimate an expected term. Expected volatility is based on the historical volatility of a group of peer entities. Dividend yields are based upon historical dividend yields. Risk-free interest rates are based on the implied yields currently available on U.S. Treasury zero coupon issues with a remaining term equal to the expected term.

 

Recent Accounting Pronouncements not yet effective

 

In December 2023, the FASB issued ASU No. 2023-09, “Improvements to Income Tax Disclosures (Topic 740)” (“ASU 2023-09”). ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional information on income taxes paid. The amendment in this ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted. We are currently evaluating the impact ASU 2023-09 will have on our consolidated financial statements and related disclosures.

 

In  November 2024, the FASB issued ASU No. 2024-03, “Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (ASC 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”), and in  January 2025, the FASB issued ASU No. 2025-01, “Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (ASC 220-40): Clarifying the Effective Date” (“ASU 2025-01”). ASU 2024-03 requires public entities to disclose additional information about specific expense categories in the notes to the financial statements. ASU 2024-03, as clarified by ASU 2025-01, is effective in annual reporting periods beginning after  December 15, 2026, and interim periods within annual reporting periods beginning after  December 15, 2027. The amendments in this ASU  may be applied either prospectively or retrospectively. Early adoption is also permitted. We are currently evaluating the impact ASU 2024-03 will have on our consolidated financial statements and related disclosures.

 

13

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 
 

3. Business Combination

 

Ydentic Acquisition

 

On January 29, 2025, the Company consummated its acquisition of 80% of the outstanding shares of Ydentic Holding B.V., which owns 100% of the outstanding equity interests of Ydentic B.V. (together, “Ydentic”). The acquisition was made pursuant to the Share Purchase Agreement, by and among the Company and the former Ydentic shareholders. The Company completed the acquisition of Ydentic to further expand its SaaS solutions for providing robust, simple, centralized multi-tenant management for managed service providers (“MSPs”) that utilize Microsoft solutions. The estimated fair value of the transaction consideration is approximately $20.4 million, consisting of $14.9 million in cash paid at closing and a $5.5 million unconditional purchase obligation with variability in the timing and amount of settlement.

 

The acquisition-related costs incurred by the Company totaled $1.3 million, of which $0.5 million was incurred during the three months ended March 31, 2025. These costs are recognized as an expense in the general and administrative item in the condensed consolidated statements of income (loss).

 

The financial results of Ydentic have been included in our condensed consolidated financial statements since the date of the acquisition. The Company established a deferred tax liability with an offset to goodwill in connection with the accounting for the opening balance sheet of the Ydentic acquisition as a result of book-to-tax differences primarily related to the technology and software intangibles and customer related assets.

 

The valuation of assets acquired and liabilities assumed has not yet been finalized as of  March 31, 2025. The purchase price allocation is preliminary and subject to change, including the valuation of intangible assets, income taxes, and goodwill, among other items. The amounts recognized will be finalized as the information necessary to complete the analysis is obtained, but no later than one year after the acquisition date. Finalization of the valuation during the measurement period could result in a change in the amounts recorded for the acquisition date fair value.

 

The following table summarizes the preliminary fair value of assets acquired and liabilities assumed as of the acquisition date:

 

  

Preliminary Allocation

 
  

(in thousands)

 

Accounts receivable, net

 $618 

Prepaid expenses and other current assets

  30 

Property and equipment, net

  68 

Goodwill

  18,214 

Intangible assets, net

  2,802 

Operating lease right-of-use assets

  562 

Other assets

  30 

Accounts payable

  (340)

Accrued expenses and other current liabilities

  (410)

Current portion of deferred revenue

  (2)

Long-term operating lease liabilities

  (457)

Other liabilities

  (723)

Total purchase consideration, net of cash acquired

 $20,392 

 

14

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 

 

 

The goodwill, which is generally not tax-deductible, is attributed to intangible assets that do not qualify for separate recognition, including the assembled workforce of the acquired business and the synergies expected to arise as a result of the acquisition.

 

The following table summarizes the purchase price allocated to the intangible assets acquired:

 

  

Amount

  

Weighted Average Life

 
  

(in thousands)

  

(in years)

 

Technology and software

 $2,283   4.0 

Customer related assets

  519   5.0 

Fair value of intangible assets acquired

 $2,802   4.2 

 

The estimated fair values of identifiable intangible assets were determined using the multiperiod excess earnings method and distributor method. The multiperiod excess earnings method is a method of estimating the value of the primary income-generating intangible asset within a group of assets, by calculating the cash flow attributable to that asset after deducting contributory asset charges. The distributor method is a form of the multiperiod excess earnings method that relies upon market-based distributor data to value customer relationship intangible assets. Some of the significant assumptions inherent in the development of such asset valuations include revenues, contributory asset charges, discount rate and useful life. The fair value of intangible assets as of March 31, 2025 is based on publicly available benchmarking information as well as preliminary assumptions which are subject to change as we complete our valuation procedures.

 

Mandatorily Redeemable Noncontrolling Interest

 

As part of the acquisition, the Company agreed to purchase the remaining 20% of the outstanding shares of Ydentic. The unconditional purchase obligation is a liability-classified mandatorily redeemable noncontrolling interest with subsequent measurement at its estimated redemption value. The liability was initially recognized at fair value of $5.5 million. The Company estimated the fair value of the mandatorily redeemable noncontrolling interest using a Monte Carlo simulation model, with the significant input of risk-free rate at 4.27%. The model incorporated multiple random iterations, simulating various potential future price paths over the contractual life of the noncontrolling interest shares, based on appropriate probability distributions.

 

Subsequent to the initial measurement, mandatorily redeemable noncontrolling interests are measured at the amount of cash that would be paid under the conditions specified in the applicable agreement, assuming settlement occurred as of the reporting date. Any change in the estimated redemption amount compared to the prior reporting date is recognized as interest cost in the condensed consolidated statements of operations.

 

As of March 31, 2025, the liability was $6.6 million and is included in accrued expenses and other current liabilities within the condensed consolidated balance sheets. During the three months ended March 31, 2025, the Company recorded interest expense of $0.8 million to adjust the redemption value of the mandatorily redeemable noncontrolling interest. The expenses are included in other income, net within the condensed statements of income (loss).

 

15

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 

 

 

4. Goodwill

 

The changes in the carrying amounts of goodwill were as follows:

 

  

Goodwill

 
  

(in thousands)

 

Balance, December 31, 2024

 $17,715 

Acquisitions

  18,214 

Effect of foreign currency translation

  845 

Balance, March 31, 2025

 $36,774 

 

 

 

5. Intangible Assets, Net

 

Intangible assets consist of acquired intangible assets and self-developed software.

 

A summary of the balances of the Company’s intangible assets as of  March 31, 2025 and  December 31, 2024 is presented below:

 

  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

 
  March 31, 2025  December 31, 2024 
  

(in thousands)

 

Technology and software

 $11,782  $(4,050) $7,732  $8,906  $(3,446) $5,460 

Customer related assets

  4,883   (1,170)  3,713   4,329   (1,036)  3,293 

Content

  830   (761)  69   818   (682)  136 

Total

 $17,495  $(5,981) $11,514  $14,053  $(5,164) $8,889 

 

Amortization expense for intangible assets was $0.8 million for the three months ended March 31, 2025, and $0.6 million for the three months ended  March 31, 2024.

 

As of March 31, 2025, estimated future amortization expense for intangible assets, net is as follows:

 

Year Ending December 31:

    
  

(in thousands)

 

2025 (nine months)

 $2,254 

2026

  2,612 

2027

  2,094 

2028

  1,985 

2029

  859 

Thereafter

  1,710 

Total intangible assets subject to amortization

 $11,514 

 

 

16

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 
 

6. Accounts Receivable, Net

 

Accounts receivable, net, consists of the following components:

 

  

March 31,

  

December 31,

 
  

2025

  

2024

 
  

(in thousands)

 

Trade receivables

 $60,126  $68,007 

Current unbilled receivables

  20,998   20,205 

Allowance for credit losses

  (1,000)  (847)
  $80,124  $87,365 

 

 

7. Line of Credit

 

The Company maintains a loan and security agreement (the “Loan Agreement”) with HSBC Bank USA, National Association, (“HSBC”) as lender, for a revolving line of credit of up to $30.0 million, with an accordion feature that provides up to $20.0 million of additional borrowing capacity the Company may draw upon at its request. Of the $30.0 million line of credit, a sublimit of approximately $5.3 million is designated to facilitate the issuance of bank guarantees, including letters of credit. The line bears interest at a rate equal to term SOFR plus 3.0% to 3.3% depending on the Consolidated Total Leverage Ratio (as defined in the Loan Agreement). The line carries an unused fee at a rate equal to 0.5%. The line will mature on November 3, 2026. We are required to maintain a minimum Consolidated Fixed Charge Coverage Ratio (as defined in the Loan Agreement) as well as a maximum Consolidated Total Leverage Ratio, tested by HSBC each quarter. The Company pledged, assigned and granted HSBC a security interest in all shares of its subsidiaries, future proceeds and assets (except for excluded assets, including material intellectual property) as security for the performance of the Loan Agreement obligations. As of March 31, 2025, the Company is compliant with all covenants under the line and had no borrowings outstanding under the line of credit.

 

 

8. Income Taxes

 

The Company had an effective tax rate of 26.8% for the three months ended March 31, 2025, and 1062.6% for the three months ended  March 31, 2024.

 

The change in effective tax rates for the three-month period ended March 31, 2025 as compared to the three-month period ended  March 31, 2024 was primarily due to the mix of pre-tax income (loss) results by jurisdictions taxed at different rates, the impact of foreign inclusions and stock-based compensation.

 

The Company continues to evaluate the realizability of its deferred tax assets on a quarterly basis and will adjust such amounts in light of changing facts and circumstances. In making such an assessment, management would consider all available supporting data, including the level of historical taxable income, future reversals of existing temporary differences, tax planning strategies, and projected future taxable income.

 

17

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 
 

9. Leases

 

The Company is obligated under various non-cancelable operating leases primarily for office space. The initial terms of the leases expire on various dates through 2030. We determine if an arrangement is a lease at inception.

 

The components of the Company’s operating lease expenses are reflected in the condensed consolidated statements of income (loss) as follows:

 

  

Three Months Ended March 31,

 
  

2025

  

2024

 
  

(in thousands)

 

Lease liability cost

 $2,063  $1,720 

Short-term lease expenses (1)

  427   267 

Variable lease cost not included in the lease liability (2)

  131   135 

Total lease cost

 $2,621  $2,122 

 

(1) Short-term lease expenses include rent expenses from leases of 12 months or less on the transition date or lease commencement.

(2) Variable lease cost includes common area maintenance, property taxes, and fluctuations in rent due to a change in an index or rate.

 

Our lease agreements generally contain lease and non-lease components. Non-lease components primarily include payments for maintenance and utilities. We elected to combine fixed payments for non-lease components, for all classes of underlying assets, with our lease payments and account for them together as a single lease component which increases the amount of our lease assets and liabilities.

 

During the three months ended March 31, 2025 and 2024, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $3.6 million and $0.7 million, respectively.

 

Other information related to operating leases is as follows:

 

  

Three Months Ended March 31,

 
  

2025

  

2024

 
  

(in thousands)

 

Cash paid for amounts included in the measurement of the lease liability:

        

Operating cash flows from operating leases

 $2,462  $2,124 

 

As of March 31, 2025, our operating leases had a weighted average remaining lease term of 3.2 years and a weighted average discount rate of 5.5%.

 

18

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)

 

 
As of December 31, 2024, our operating leases had a weighted average remaining lease term of 3.3 years and a weighted average discount rate of 5.2%.
 
The maturity schedule of the operating lease liabilities as of March 31, 2025 is as follows:

 

Year Ending December 31:

    
  

(in thousands)

 

2025 (nine months)

 $5,821 

2026

  6,465 

2027

  4,304 

2028

  1,530 

2029

  1,027 

Thereafter

  525 

Total future lease payments

  19,672 

Less: Present value adjustment

  (1,666)

Present value of future lease payments (1)

 $18,006 

 

(1) Includes the current portion of operating lease liabilities of $6.4 million, which is reflected in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

 

As of March 31, 2025, letters of credit have been issued in the amount of $1.0 million as security for operating leases. The letters of credit are secured by certificates of deposit and a sublimit of our line of credit (refer to “Note 7 - Line of Credit” for further details). The certificates of deposit are included in short-term investments and other assets within the condensed consolidated balance sheets.

 

19

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 
 

10. Commitments and Contingencies

 

Commitments

 

The Company has outstanding unconditional purchase commitments to procure licenses to use information technology (“IT”) software from suppliers. These agreements are negotiated in consideration of the volume of transactions with select suppliers and the associated required transaction volumes are expected to be met through the normal course of business.

 

In  December 2022, the Company signed an unconditional purchase commitment in the amount of $96.0 million to purchase IT solutions over a three-year term. Under this agreement, payments are made upon access to the service. Any remaining obligations are due at the end of the three-year term in  December 2025 as specified in the agreement. Given the Company’s history of procuring similar products, it is expected that cash payments to the supplier will occur in 2023 through 2025 with any remaining amounts coming due in 2025. During the three months ended  March 31, 2025 and 2024, the Company paid $8.2 million and $6.7 million, respectively, related to the  December 2022 agreement. 

 

In  December 2024, the Company signed an unconditional purchase commitment in the amount of $15.0 million to purchase additional IT solutions over a five-year term. Under this agreement, payments are made upon access to the service. The agreement specified four minimum commitment periods. The minimum commitment payments are due at the end of each minimum commitment period.

 

In  February 2024, the Company made a commitment to contribute $50.0 million to a growth equity fund. As of March 31, 2025, this commitment remains outstanding. Refer to “Note 13 - Growth Equity Fund” for more information.

 

Legal Proceedings

 

In the normal course of its business, the Company may be involved in various claims, negotiations and legal actions. Except for such claims that arise in the normal course of business, as of March 31, 2025, the Company was not a party to any other litigation.

 

Indemnification

 

The Company has entered into indemnification agreements with its executive officers and directors. These agreements, among other things, require AvePoint to indemnify its directors and executive officers to the fullest extent permitted by Delaware law, specifically the Delaware General Corporation Law (as the same exists or may hereafter be amended) for certain expenses, including attorneys’ fees, judgments, fines, and settlement amounts incurred by a director or officer in any action or proceeding arising out of their services as one of the Company’s directors or officers or any other company or enterprise to which the person provides services at the Company’s request.

 

As part of the business combination with Apex Technology Acquisition Corporation, Inc. (“Apex”), we assumed certain indemnification obligations for Apex Technology Sponsor LLC and Jeff Epstein, Brad Koenig, David Chao, Peter Bell, Donna Wells, and Alex Vieux (the “Indemnitees” or “Defendants”). On February 2, 2024, Drulias and Farzad (as purported Apex stockholders, the “Plaintiffs”) filed a class action complaint against the Indemnities in Delaware Court of Chancery, captioned Dean William Drulias, et.al. v. Apex Technology Sponsor LLC, et.al., C.A. No. 2024-0094-LWW. Plaintiffs asserted breach of fiduciary duty and unjust enrichment claims against the Defendants. The complaint alleged that Defendants made false and misleading disclosures in the June 2, 2021 proxy statement of Apex impacting its stockholders’ vote to approve a merger between Apex and us and also affecting stockholders’ redemption rights prior to the merger. Plaintiffs sought unspecified damages, rescission or rescissory damages, and disgorgement of unjust enrichment. We were not a named defendant in the complaint but had indemnification obligations to the Defendants under indemnification agreements executed during the merger. Also, in accordance with the business combination agreement, the Defendants obtained insurance policies to cover post-closing liability, with Apex securing a policy with a limit of $10 million and the sponsors obtaining a policy with a $3 million limit. The parties participated in a mediation in October and agreed to settlement terms. Pursuant to a signed letter of intent and a forthcoming settlement agreement, releasing us and the Defendants and settling the class action, we will contribute $1.4 million toward the full settlement amount of $14.4 million. The remaining $13 million will be paid pursuant to the two aforementioned insurance policies covering the Defendants and sponsor. As of March 31, 2025 and December 31, 2024, an estimated accrual of $1.4 million was included in the accrued expenses and other current liabilities within the condensed consolidated balance sheets.

 

Guarantees

 

In the normal course of business, customers in certain geographies or in highly regulated sectors occasionally require contingency agreements for the completion of service projects, the completion of which are secured by certificates of deposit and a sublimit of our line of credit (refer to “Note 7 - Line of Credit” for further details). The certificates of deposit are included in short-term investments within the condensed consolidated balance sheets. As of March 31, 2025, letters of credit for customer-related contingency agreements have been issued in the amount of $4.8 million, as security for the agreements. These agreements have not had a material effect on our results of operations, financial position or cash flow.

 

20

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 
 

11. Warrant Liabilities

 

Private Warrants to Acquire Common Stock

 

On July 1, 2021, the Company granted 405,000 private placement warrants with a 5-year term and an exercise price of $11.50 per share. Management has determined that the private placement warrants are to be classified as liabilities to be marked to market at each reporting period.

 

The private placement warrants are non-transferable and any transfer to an unrelated party would cause the warrants to be converted into public warrants. Consequently, the fair value of the private placement warrants is equivalent to the quoted price of the publicly traded warrants. Under this approach, the fair value of the private placement warrants on July 1, 2021, was determined to be $1.4 million. The fair value was remeasured as of March 31, 2025 and December 31, 2024, and was determined to be $1.4 million and $1.9 million, respectively, and included in other liabilities in the condensed consolidated balance sheets. As a result, a $0.5 million gain was recognized during the three months ended March 31, 2025, and a $0.1 million loss was recognized during the three months ended  March 31, 2024, and included as other income, net in the condensed consolidated statements of income (loss).

 

As of March 31, 2025, 328,750 private placement warrants remained outstanding.

 

12. Stockholders Equity

 

The Company has one class of capital stock: common stock. The following summarizes the terms of the Company’s capital stock.

 

Common Stock

 

Pursuant to the Company’s restated Articles of Incorporation, the Company was authorized to issue up to 1,000,000,000 shares of common stock at $0.0001 par value. There were 203,030,980 and 194,070,512 shares issued and outstanding as of  March 31, 2025 and December 31, 2024, respectively. Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Company’s Board of Directors. The Company’s Board of Directors has not declared common stock dividends since inception.

 

Share Repurchase Program

 

On March 17, 2022, the Company announced that its Board of Directors authorized a new share repurchase program (the “Share Repurchase Program”) for the Company to buy back shares of its common stock for a period of three years from the date of authorization. On February 25, 2025, the Company’s Board of Directors renewed the Share Repurchase Program for an additional three years from the date of renewal. Under the Share Repurchase Program, the Company has the authority to buy up to $150 million of common stock via acquisitions in the open market or privately negotiated transactions. The Share Repurchase Program may be suspended or discontinued at any time. The Company is not obligated to make purchases of, nor is it obligated to acquire any particular amount of, common stock under the Share Repurchase Program. During the three months ended March 31, 2025, the Company repurchased and retired 800,995 shares at an average price of $14.86 per share. The shares were returned to the status of authorized but unissued shares. As a result, common stock amount, additional paid-in capital, and accumulated deficit in the condensed consolidated balance sheet during the three months ended March 31, 2025, were reduced by $0.0 million, $3.4 million, and $8.5 million, respectively. During the three months ended  March 31, 2024, the Company repurchased and retired 1,758,850 shares at an average price of $7.81 per share.

 

21

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)

 

Public Warrants to Acquire Common Stock

 

On July 1, 2021, the Company issued 17,500,000 public warrants with an exercise price of $11.50. Each warrant entitles the registered holder to purchase one share of AvePoint’s common stock and the warrants are exercisable from the date of issuance through July 1, 2026.

 

During the three months ended March 31, 2025, 7,595,099 warrants were exercised, with total cash received of $87.3 million. As of  March 31, 2025, 6,890,701 warrants remained outstanding.

 

13. Growth Equity Fund

 

On February 28, 2024, the Company and Lumens Capital Partners Ltd. (“LCP”) established A3V JV Co. (the “Venture”), with each owning an equal share of the Venture. In addition, the Company entered into a separate agreement with LCP to form A3 Ventures Fund 1, L.P. (the “Fund”). The Fund is a Cayman Islands-exempted limited partnership, aimed at investing in companies in the growth equity phase and mature cashflow generating businesses with strong growth potential. The Fund looks to invest in companies situated in enterprise software markets aligning with the professional expertise and geographical presence of both the Company and LCP.

 

The Venture wholly owns A3V GP Co., which serves as the general partner of the Fund. As a limited partner, the Company committed to contribute $50.0 million to the Fund, to be called as needed, for portfolio investments, fees, and expenses of the Fund. The Company also participates in Fund establishment costs and an annual management fee equal to 2.0% of the total commitment. Any future repayment obligations will be triggered upon the receipt by LCP of profit allocations related to the Fund.

 

As of March 31, 2025, no portion of the Company’s $50.0 million commitment has been called or was callable, and the operations of the Fund and the Venture have not materially impacted the Company’s financial position, financial performance, or cash flows.

 

As of  March 31, 2025 and December 31, 2024, management fees and establishment costs of $2.7 million and $2.4 million, respectively, were included in accrued expenses and other liabilities in the condensed consolidated balance sheets. During the three months ended March 31, 2025 and 2024, management fees and establishment costs of $0.3 million and $0.6 million, respectively, were included in general and administrative in the condensed consolidated statements of income (loss).

 

22

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 
 

14. Stock-Based Compensation

 

The Company maintains the 2021 Equity Incentive Plan (the “2021 Plan”). As of March 31, 2025, 24,276,338 shares remained for future issuance under the 2021 Plan. To date, the Company has issued only stock options and restricted stock units to employees, directors and consultants.

 

For the three months ended March 31, 2025 and 2024, total stock-based compensation expense was $9.6 million and $9.5 million, respectively. 

 

Stock Options

 

The compensation costs for stock option awards are recognized using the straight-line attribution method over the requisite service period and are accounted for forfeitures as they occur. Stock options vest over a four-year service period and expire on the tenth anniversary of the date of award. 

 

On March 14, 2025, the Company granted 269,685 options under the 2021 Plan. The Company estimated the grant date fair value of these stock options using the Black-Scholes option-pricing model with the following weighted-average assumptions:

 

  March 14, 
  2025 
Expected life (in years)  6.1 
Expected volatility  55.6%
Risk-free rate  4.1%
Dividend yield   

 

To estimate the expected life of stock options, the Company considered the vesting term, contractual expiration period, and market conditions. Expected volatility is based on historical volatility of a group of peer entities. Dividend yields are based upon historical dividend yields. Risk-free interest rates are based on the implied yields currently available on U.S. Treasury zero coupon issues with a remaining term equal to the expected life. Based on these inputs, the grant-date fair value was determined to be $2.2 million.

 

As of March 31, 2025, there was $7.4 million in unrecognized compensation costs related to all unvested options.

 

As of  March 31, 2025, the Company had 23,131,333 options outstanding and 21,237,602 options exercisable with intrinsic values of $230.3 million and $218.4 million, respectively. During the three months ended March 31, 2025, 418,369 options were exercised, with a total intrinsic value of $5.9 million.

 

23

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)

 

Restricted Stock Units

 

Under the terms of the 2021 Plan, we have issued restricted stock unit awards with a continuous employment condition only (“Time-Based RSUs”), and restricted stock unit awards with a continuous employment condition that are also contingent on the Company meeting certain performance goals (“PSUs”, and together “RSUs”). Both types of RSU awards vest over a four-year period from the grant date.

 

2,041,643 Time-Based RSUs and 301,842 PSUs were granted under the 2021 Plan during the three months ended March 31, 2025, with a weighted-average grant date fair-value of $14.66 per award. The compensation costs for RSUs are recognized using the straight-line attribution method over the requisite service period and are accounted for forfeitures as they occur. RSUs are measured at the fair market value of the underlying stock at the grant date. RSUs that vested during the three months ended  March 31, 2025 had an aggregate fair value at vesting of $26.2 million. As of March 31, 2025, there was $79.5 million in unrecognized compensation costs specific to the unvested RSUs, to be recognized over a weighted-average period of 2.9 years. As of  March 31, 2025, the Company had 9,423,644 unvested Time-Based RSUs and 804,518 unvested PSUs with a weighted-average grant date fair-value of $8.19 per award.

 

 

15. Fair Value Measurements

 

Fair value is the price that would be received upon selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value are measured and classified in accordance with a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

 

 

Level 1 — Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.

 

 

Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

 

 

Level 3 — Unobservable inputs for the asset or liability.

   

 

24

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 

 

 

  

March 31, 2025

 
  

(in thousands)

 
  

Level 1

  

Level 2

  

Level 3

  

Total

 

Assets

                

Cash Equivalents:

                

Certificates of deposit (1)

 $  $1,575  $  $1,575 

Money market funds

     4,177      4,177 

U.S. treasury bills

     183,139      183,139 

Short-term investments:

                

Certificates of deposit (1)

     326      326 

Other assets:

                

Certificates of deposit (1)

     195      195 

Notes receivables (2)

        4,065   4,065 

Total

 $  $189,412  $4,065  $193,477 

Liabilities:

                

Accrued expenses and other current liabilities:

                

Mandatorily redeemable noncontrolling interest (3)

 $  $  $6,306  $6,306 

Other non-current liabilities:

                

Warrant liabilities (4)

     1,387      1,387 

Total

 $  $1,387  $6,306  $7,693 

 

  

December 31, 2024

 
  

(in thousands)

 
  

Level 1

  

Level 2

  

Level 3

  

Total

 

Assets

                

Cash Equivalents:

                

Certificates of deposit (1)

 $  $1,504  $  $1,504 

Money market funds

     4,188      4,188 

U.S. treasury bills

     181,210      181,210 

Short term investments:

                

Certificates of deposit (1)

     165      165 

Other assets:

                

Certificates of deposit (1)

     39      39 

Notes receivables (2)

        3,938   3,938 

Total

 $  $187,106  $3,938  $191,044 

Liabilities:

                

Other liabilities:

                

Warrant liabilities (4)

 $  $1,861  $  $1,861 

Total

 $  $1,861  $  $1,861 

 

(1The majority of certificates of deposit are foreign deposits.

(2) During 2023, the Company extended a credit facility to LCP with a total commitment of up to $5.0 million and maturities of greater than twelve months (the “LCP Notes Receivable”). Refer to “Note 13 Growth Equity Fund” for further details. The LCP Notes Receivable bear interest at an annual rate equal to 8%. As of  March 31, 2025 and December 31, 2024, the LCP Notes Receivable in the amounts of $3.9 million and $3.8 million, respectively, were included in other assets within the condensed consolidated balance sheets. Fair values are based on discounted future cash flows using current interest rates offered for similar notes to third parties with similar credit ratings for the same remaining maturities.

(3) The fair value of mandatorily redeemable noncontrolling interest is based on discounted redemption value using risk-free rates offered for similar financing with the same remaining maturities.

(4Refer to “Note 11 — Warrant Liabilities” for further details.

 

25

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 

The following tables summarize the Company’s available-for-sale securities measured at fair value as of March 31, 2025 and December 31, 2024.

 

  

March 31, 2025

 
  

(in thousands)

 
  

Amortized Cost

  

Fair Value

  

Gross Unrealized Losses

 

U.S. treasury bills

 $183,158  $183,139  $(19)

Total

 $183,158  $183,139  $(19)

 

  

December 31, 2024

 
  

(in thousands)

 
  

Amortized Cost

  

Fair Value

  

Gross Unrealized Losses

 

U.S. treasury bills

 $181,217  $181,210  $(7)

Total

 $181,217  $181,210  $(7)

 

The contractual maturity of the available-for-sale securities held as of March 31, 2025 and December 31, 2024 was within one year.

 

 

16. Segment Information

 

The Company manages its business activities on a consolidated basis and operates in a single operating segment. Its products and services are sold throughout the world, through direct and indirect sales channels. The Company’s chief operating decision maker (the “CODM”) is the Chief Executive Officer. The CODM makes operating performance assessment and resource allocation decisions on a consolidated basis. The CODM does not review assets in evaluating the results of the segment.

 

The accounting policies of the segment are the same as those described in “Note 2 - Summary of Significant Accounting Policies”. The CODM assesses performance for the consolidated entity and decides how to allocate resources based on net income (loss) reported on the consolidated statements of income (loss). The CODM uses net income (loss) to monitor budgeted versus actual results and to conduct competitive analysis by benchmarking against industry peers. Additionally, net income (loss) serves as a basis for making strategic decisions, such as acquisitions and reinvestments into the business, and establishing management compensation linked to segment performance.

 

The following table sets forth the information about the Company’s reported segment revenue, segment profit or loss, and significant segment expenses:

 

  

Three Months Ended March 31,

 
  

2025

  

2024

 
  

(in thousands)

 

Revenue:

 $93,064  $74,534 
         

Less:

        

People expenses

  52,807   45,615 

Stock-based compensation

  9,620   9,458 

Cloud and server hosting services expenses

  9,482   7,732 

Marketing expenses

  4,126   2,739 

Other segment items (1)

  13,463   10,944 

Net income (loss)

 $3,566  $(1,954)

 

(1) The other segment items category includes professional services, rent, software maintenance, travel, depreciation and amortization, certain overhead expense, and mark-to-market of earn-out shares liabilities and warrant liabilities.

 

26

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 

Revenue by geography is based upon the billing address of the customer. All transfers between geographic regions have been eliminated from consolidated revenue. The following table sets forth revenue by geographic area:

 

  

Three Months Ended March 31,

 
  

2025

  

2024

 
  

(in thousands)

 

Revenue:

        

North America

 $36,452  $29,895 

EMEA

  29,484   22,806 

APAC

  27,128   21,833 

Total revenue

 $93,064  $74,534 

 

The following table sets forth revenue generated by countries which represent more than 10% of total consolidated revenue:

 

  

Three Months Ended March 31,

 
  

2025

  

2024

 
  

(in thousands)

 

Revenue:

        

United States

 $36,399  $29,697 

Germany

  12,292   9,894 

Singapore

  11,512   10,479 

 

27

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 
 

17. Other Income, Net

 

Other income, net is disaggregated as follows:

 

  

Three Months Ended March 31,

 
  

2025

  

2024

 
  

(in thousands)

 

Gain on earn-out and warrant liabilities

 $473  $1,490 

Interest (expense) income, net

  (299)  34 

Profits on securities (1)

  1,931   2,417 

Foreign currency exchange loss, net

  (330)  (568)

Other, net

  (189)  31 

Other income, net

 $1,586  $3,404 

 

(1) Profits on securities consist of interest income from amortization of the discount arising at acquisition of U.S. treasury bills.

 

18. Net Income (Loss) Per Share

 

Basic net income (loss) per share is computed by dividing total net income (loss) by the weighted average common shares outstanding for the period. In computing diluted net income (loss) per share, the Company adjusts the denominator, subject to anti-dilution requirements, to include the dilution from potential shares of common stock resulting from outstanding share-based payment awards and warrants.

 

  

Three Months Ended March 31,

 
  

2025

  

2024

 
  

(in thousands, except per share amounts)

 

Net income (loss) per share available to common stockholders, excluding sponsor earn-out stockholders

        

Numerator:

        

Net income (loss)

 $3,566  $(1,954)

Net (income) loss attributable to noncontrolling interest

  (126)  238 

Total net income (loss) available to common stockholders

 $3,440  $(1,716)

Denominator:

        

Weighted average common shares outstanding

  197,924   181,495 

Effect of dilutive securities

        

Stock options

  16,789    

RSUs

  6,284    

Warrants

  3,576    

Weighted average diluted shares

  224,573   181,495 
         

Basic net income (loss) per share available to common stockholders, excluding sponsor earn-out stockholders

 $0.02  $(0.01)

Diluted net income (loss) per share available to common stockholders, excluding sponsor earn-out stockholders

 $0.02  $(0.01)

 

 

28

AvePoint, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 

The below table includes the total potentially dilutive securities for the three months ending  March 31, 2025 and 2024, which have been excluded from the computation of diluted net income (loss) per share as their effect is anti-dilutive:

 

  

Three Months Ended March 31,

 
  

2025

  

2024

 
  

(in thousands)

 

Stock options

  20   26,813 

RSUs

     12,394 

Warrants

     17,905 

Earn-out shares

     3,000 

Total

  20   60,112 

 

 

19. Subsequent Events

 

The following material subsequent event occurred since the date of the most recent balance sheet period reported.

 

At the end of March 2025, the Company offered to purchase all of the remaining outstanding interest of MaivenPoint Ptd. Ltd. (“MaivenPoint”) from the remaining minority interest holders for an aggregate total of approximately $11.6 million in cash. As of the end of April, all minority interest holders accepted the Company’s offer subject to acceptable terms and conditions to be drafted in a shareholder purchase agreement in May 2025.  Following the acquisition of the interest, the Company will be the sole interest holder in MaivenPoint.

 

 
 
 

 

29

Part I
Item 2

 

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (Part I, Item 2 of this Quarterly Report) (“MD&A”) summarizes (and is intended to help the reader understand) the significant factors affecting the consolidated operating results, financial condition, liquidity and cash flows of our Company as of and for the periods presented below. The MD&A should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2024 (our “Annual Report”) and our condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report. 

 

First Quarter 2025 Business Highlights

 

 

Total annual recurring revenue (“ARR”) increased 26% year-over-year to $345.5 million as of March 31, 2025, 28% adjusted for FX;

 

Total revenue increased 25% year-over-year to $93.1 million for the three months ended March 31, 2025, 27% on a constant currency basis;
  SaaS revenue increased 34% year-over-year to $68.9 million for the three months ended March 31, 2025, 37% on a constant currency basis;
  Completed the acquisition of Ydentic to provide MSPs with an AI-driven platform to manage, optimize, and secure clients’ IT environments;
  Launched the next generation of AvePoint Elements to automate insights, secure data, and accelerate profitability and efficiency for MSPs building security-centric practices; and
  Released new data security solutions for Google, expanding the Company’s multi-cloud protection to empower organizations with intelligent risk identification, proactive threat monitoring, and incident response at scale.

 

Overview

 

AvePoint empowers organizations of all sizes, industries, and regions with its cloud-native data management software platform, enabling them to prepare, secure, and optimize their critical data. The AvePoint Confidence Platform unifies data security, governance, and business continuity into a seamless, resilient experience, addressing the most pressing challenges in today’s complex digital landscape.

 

In a world where data is sprawling across hybrid work environments and generative artificial intelligence (“AI”) technologies are rapidly emerging, AvePoint stands out with its platform-first strategy. By integrating features and solutions to optimize operations, AvePoint delivers more than basic security controls—it redefines how businesses manage their most sensitive data and critical assets. This holistic and automated approach enables organizations to secure the perimeter for sensitive data, strategically govern digital workspaces, and ensure compliance with evolving regulatory requirements.

 

Organizations today face a host of challenges that make a robust data management strategy indispensable, including:

 

 

Optimizing data for AI: As organizations modernize their data ecosystems, the complexities of leveraging generative AI technologies require proper governance, security, and lifecycle management. With AvePoint, companies can extract more value from complex datasets, make informed decisions, reduce workloads, and enhance customer experiences.

 

Explosive data growth: The hybrid work model and SaaS proliferation have led to a surge in unstructured, sensitive data. AvePoint’s solutions tackle the sprawl with robust control and protection measures to manage this growth.
  A dangerous threat landscape and complex regulations: Companies are navigating increasing cyber threats and global regulatory demands. AvePoint ensures data is protected, secure, and compliant, helping mitigate financial, operational, and reputational risks.
  The need for automation: To monitor, govern, and respond to threats efficiently, organizations require streamlined, automated platforms that deliver rapid value. AvePoint’s automation layer integrates seamlessly to achieve this efficiency.

 

Guided by its Beyond Secure philosophy, AvePoint goes beyond traditional boundaries to inspire trust, enabling organizations to focus on innovation while protecting against data breaches and unauthorized access. For over 20 years, AvePoint has continually innovated to provide solutions that meet the demands of modern data management, empowering businesses to overcome challenges and unlock new possibilities in an ever-evolving landscape.

 

30

Part I
Item 2

 

Key Business Metric

 

Our management reviews the following key business metric to measure our performance, identify trends affecting our business, formulate business plans, make strategic decisions, and effectively allocate resources. We believe that both management and investors benefit from referring to this metric to evaluate progress against our growth strategies and gain additional transparency into performance trends.

   

March 31,

 
   

2025

   

2024

 

Total ARR ($ in mil)

  $ 345.5     $ 274.5  

 

Annual Recurring Revenue

 

We believe ARR further enables measurement of our business performance, is an important metric for financial forecasting, and better enables us to make strategic business decisions. We calculate ARR as the annualized sum of contractually obligated Annual Contract Value (“ACV”) from SaaS, term license and support, and maintenance revenue sources from all active customers at the end of a reporting period.

 

As of March 31, 2025 and 2024, total ARR was $345.5 million and $274.5 million, respectively, representing growth of 26%. Adjusted for FX, total ARR increased 28% year over year. 

 

Growth in ARR is driven by both new customer acquisitions and the expansion of existing customer relationships. ARR should be viewed independently of revenue and deferred revenue and is not intended to be combined with or replace these items. ARR is not a forecast of future revenue, and the active contracts used in calculating ARR may or may not be extended or renewed by our customers.

 

31

Part I
Item 2

 

Components of Results of Operations

 

Revenue

 

We generate revenue from four primary sources: SaaS, term license and support, services, and maintenance. We consider SaaS, term license and support, and maintenance revenues to be recurring.

 

SaaS revenues are generated from our cloud-based solutions. Term license and support revenues are generated from the sales of on-premise or hybrid licenses, which include a distinct support component. Both SaaS and term license and support revenues are primarily billed annually. SaaS and term license and support are generally sold per user license or based upon the amount of data protected. SaaS revenue is recognized ratably over the term of the contract. For term license and support revenue, the license component is generally recognized upfront at the point in time when the software is made available to the customer to download and use, and the support component is recognized ratably over the term of the contract.

 

Services revenue includes revenue generated from implementation, training, consulting, license customization and managed services. These revenues are recognized by applying a measure of progress, such as labor hours, to determine the percentage of completion of each contract. These offerings are not inherently recurring in nature and as such are subject to more period-to-period volatility than other elements of our business. Services revenue from managed services are recognized ratably or on a straight-line basis over the contract term.

 

Maintenance revenue is a result of selling on-going support for legacy perpetual licenses. It also includes recurring professional services such as technical account management. Maintenance revenue is recognized ratably over the term of the maintenance agreement, which is typically one year.

     

Cost of Revenue

 

Cost of SaaS and cost of term license and support consists of all direct costs to deliver and support our SaaS and term license and support products, including salaries, benefits, stock-based compensation and related expenses, overhead, third-party hosting fees related to our cloud services, and depreciation and amortization. We recognize these expenses as they are incurred. We expect that these costs will increase in absolute dollars but may fluctuate as a percentage of SaaS and term license and support revenue from period to period.

 

Cost of maintenance consists of all direct costs to support our legacy perpetual license products, including salaries, benefits, stock-based compensation and related expenses, overhead, and depreciation and amortization. We recognize these expenses as they are incurred. We expect that cost of maintenance revenue will decrease in absolute dollars as maintenance revenue declines but may fluctuate as a percentage of maintenance revenue.

 

Cost of services consists of salaries, benefits, stock-based compensation and related expenses for our services organization, overhead, technology necessary to service our customers, and depreciation and amortization. We recognize these expenses as they are incurred.

     

Gross Profit and Gross Margin

 

Gross profit is revenue less cost of revenue, and gross margin is gross profit as a percentage of revenue.

 

Gross profit has been and will continue to be affected by various factors, including the mix of our revenue, the costs associated with third-party cloud-based hosting services for our cloud-based subscriptions, and the extent to which we expand our customer support and services organizations. We expect that our gross margin will fluctuate from period to period depending on the interplay of these various factors but should increase in the long term as SaaS revenue continues to increase as a percentage of total revenue.

     

Sales and Marketing

 

Sales and marketing expenses consist primarily of personnel-related expenses for sales, marketing and customer success personnel, stock-based compensation expense, sales commissions, marketing programs, travel-related expenses, overhead costs, depreciation and amortization. We focus our sales and marketing efforts on creating sales leads and establishing and promoting our brand. Incremental sales commissions for new customer contracts are deferred and amortized ratably over the estimated period of our relationship with such customers. We plan to continue our investment in sales and marketing by hiring additional sales and marketing personnel, executing our go-to-market strategy globally, and building our brand awareness.

 

32

Part I
Item 2

 

General and Administrative

 

General and administrative expenses consist primarily of personnel-related expenses for finance, legal and compliance, human resources, and IT personnel, as well as stock-based compensation expense, external professional services, overhead costs, other administrative functions, depreciation and amortization. 

     

Research and Development

 

Research and development expenses consist primarily of personnel-related expenses incurred for our engineering and product and design teams, as well as stock-based compensation expense, overhead costs, depreciation and amortization. We have a geographically dispersed research and development presence in the United States, China, Singapore and Vietnam. We believe this provides a strategic advantage, allowing us to invest efficiently in both new product development and increasing our existing product capabilities. We believe delivering expanding product functionality is critical to enhancing the success of existing customers while new product development further reinforces our breadth of software solutions.

     

Other Income, net

 

Other Income, net consists primarily of fair value adjustments on earn-out and warrant liabilities, realized gain/loss for securities, and of foreign currency remeasurement gains/losses.

     

Income Taxes

 

We are subject to income taxes in the U.S. (federal and state) and numerous foreign jurisdictions. Tax laws, regulations, administrative practices, principles, and interpretations in various jurisdictions may be subject to significant change, with or without notice, due to economic, political, and other conditions. The foreign jurisdictions in which we operate have different statutory tax rates than those of the United States. Accordingly, our effective tax rate could be affected by the relative proportion of foreign to domestic income, use of foreign tax credits, changes in the valuation of our deferred tax assets and liabilities, applicability of any valuation allowances, and changes in tax laws in jurisdictions in which we operate.

 

33

Part I
Item 2

 

Results of Operations

 

The below period-to-period comparisons of operating results are not necessarily indicative of results for future periods.

 

  

Comparison of Three Months Ended March 31, 2025 and March 31, 2024

 

Revenue

 

The components of AvePoint’s revenue during the three months ended March 31, 2025 and 2024 were as follows:

 

   

Three Months Ended

                 
   

March 31,

   

Change

 
   

2025

   

2024

   

Amount

   

%

 
   

(in thousands, except percentages)

 

Revenue:

                               

SaaS

  $ 68,942     $ 51,311     $ 17,631       34.4 %

Term license and support

    11,190       10,005       1,185       11.8 %

Services

    10,937       10,481       456       4.4 %

Maintenance

    1,995       2,737       (742 )     (27.1 )%

Total revenue

  $ 93,064     $ 74,534     $ 18,530       24.9 %

 

Total revenue increased 24.9% to $93.1 million for the three months ended March 31, 2025, primarily due to an increase in SaaS revenue, which increased 34.4% to $68.9 million, and represented 74% of total revenue, up from 69% of total revenue in the prior year. The increase in SaaS revenue, which was driven by strong customer demand for our SaaS solutions, was partially offset by an expected decrease in maintenance revenue. The growth in total revenue was also due to an increase in term license and support revenue, which grew 11.8% to $11.2 million.

 

Services revenue is expected to fluctuate as the services generally are not recurring in nature. Additionally, maintenance revenue is expected to continue declining as we have shifted away from the sale of perpetual licenses and towards SaaS and term licenses. Without perpetual license sales, there will be limited opportunities to sell maintenance contracts to new customers. Existing customers have and will continue to transition to SaaS and term licenses, which will continue the decline in maintenance revenue. 

 

Revenue by geographic region for the three months ended March 31, 2025 and 2024 was as follows:

 

   

Three Months Ended

                 
   

March 31,

   

Change

 
   

2025

   

2024

   

Amount

   

%

 
   

(in thousands, except percentages)

 

North America

  $ 36,452     $ 29,895     $ 6,557       21.9 %

EMEA

    29,484       22,806       6,678       29.3 %

APAC

    27,128       21,833       5,295       24.3 %

Total

  $ 93,064     $ 74,534     $ 18,530       24.9 %

 

For the three months ended March 31, 2025, North America revenue increased 21.9% to $36.5 million, driven by a 30.9%, or $7.1 million, increase in SaaS revenue, partially offset by a combined $0.5 million net decrease in term license and support, services, and maintenance revenues. EMEA revenues increased 29.3% to $29.5 million, driven by a 35.6%, or $6.6 million, increase in SaaS revenue. APAC revenues increased 24.3% to $27.1 million, primarily driven by a 40.0%, or $4.0 million, increase in SaaS revenue, and a 61.6%, or $1.3 million, increase in term license and support revenue.

 

On a constant currency basis, EMEA revenues increased 32.7%, while EMEA SaaS revenues increased 39.2%. On a constant currency basis, APAC revenues increased 27.1%, while APAC SaaS revenues increased 44.8%.

 

34

Part I
Item 2

 

Non-GAAP Financial Measures

 

In addition to our financial results determined in accordance with GAAP, we disclose non-GAAP cost of revenue, non-GAAP gross profit, non-GAAP gross margin, non-GAAP sales and marketing expense, non-GAAP general and administrative expense, non-GAAP research and development expense, non-GAAP operating income and non-GAAP operating margin.

 

We believe these non-GAAP measures aid investors by providing additional insight into our operational performance and into trends affecting our business. Management uses these non-GAAP financial measures to understand and compare operating results across accounting periods, for internal budgeting and forecasting purposes, and to evaluate financial performance.

 

Non-GAAP operating income and non-GAAP operating margin should not be considered as an alternative to operating income, operating margin or any other performance measures derived in accordance with GAAP as measures of performance. Non-GAAP operating income and non-GAAP operating margin should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP.

 

Cost of Revenue, Gross Profit, and Gross Margin

 

Cost of revenue, gross profit, and gross margin during the three months ended March 31, 2025 and 2024 were as follows:

 

   

Three Months Ended

                 
   

March 31,

   

Change

 
   

2025

   

2024

   

Amount

   

%

 
   

(in thousands, except percentages)

 

Cost of revenue:

                               

SaaS

  $ 12,537     $ 9,770     $ 2,767       28.3 %

Term license and support

    411       416       (5 )     (1.2 )%

Services

    10,798       10,073       725       7.2 %

Maintenance

    153       183       (30 )     (16.4 )%

Total cost of revenue

  $ 23,899     $ 20,442     $ 3,457       16.9 %

Gross profit

    69,165       54,092       15,073       27.9 %

Gross margin

    74.3 %     72.6 %            
                                 

GAAP cost of revenue

  $ 23,899     $ 20,442     $ 3,457       16.9 %

Stock-based compensation expense

    (342 )     (871 )     529       (60.7 )%

Amortization of acquired intangible assets

    (333 )     (241 )     (92 )     38.2 %

Non-GAAP cost of revenue

  $ 23,224     $ 19,330     $ 3,894       20.1 %

Non-GAAP gross profit

    69,840       55,204       14,636       26.5 %

Non-GAAP gross margin

    75.0 %     74.1 %            

 

Cost of revenue increased 16.9% to $23.9 million for the three months ended March 31, 2025, primarily driven by a $1.7 million increase from higher aggregate hosting costs resulting from increased SaaS revenue and a $1.1 million increase in personnel costs. 

 

35

Part I
Item 2

 

Operating Expenses

 

Sales and Marketing

 

Sales and marketing expenses during the three months ended March 31, 2025 and 2024 were as follows:

 

   

Three Months Ended

                 
   

March 31,

   

Change

 
   

2025

   

2024

   

Amount

   

%

 
   

(in thousands, except percentages)

 

Sales and marketing

  $ 34,522     $ 29,939     $ 4,583       15.3 %

Percentage of revenue

    37.1 %     40.2 %            
                                 

GAAP sales and marketing

  $ 34,522     $ 29,939     $ 4,583       15.3 %

Stock-based compensation expense

    (2,326 )     (2,284 )     (42 )     1.8 %

Amortization of acquired intangible assets

    (133 )     (112 )     (21 )     18.8 %

Non-GAAP sales and marketing

  $ 32,063     $ 27,543     $ 4,520       16.4 %

Non-GAAP percentage of revenue

    34.5 %     37.0 %            

 

Sales and marketing expenses increased 15.3% to $34.5 million for the three months ended March 31, 2025, primarily driven by a $2.9 million increase in personnel costs, and a $1.4 million increase in marketing spend.

 

General and Administrative

 

General and administrative expenses during the three months ended March 31, 2025 and 2024 were as follows:

 

   

Three Months Ended

                 
   

March 31,

   

Change

 
   

2025

   

2024

   

Amount

   

%

 
   

(in thousands, except percentages)

 

General and administrative

  $ 18,667     $ 16,868     $ 1,799       10.7 %

Percentage of revenue

    20.1 %     22.6 %            
                                 

GAAP general and administrative

  $ 18,667     $ 16,868     $ 1,799       10.7 %

Stock-based compensation expense

    (4,754 )     (4,967 )     213       (4.3 )%

Non-GAAP general and administrative

  $ 13,913     $ 11,901     $ 2,012       16.9 %

Non-GAAP percentage of revenue

    14.9 %     16.0 %            

 

General and administrative expenses increased 10.7% to $18.7 million for the three months ended March 31, 2025. The increase was primarily driven by $1.3 million increase in personnel costs, and an incremental $0.5 million in professional services fees related to the Ydentic acquisition.

 

36

Part I
Item 2

 

Research and Development

 

Research and development expenses during the three months ended March 31, 2025 and 2024 were as follows:

 

   

Three Months Ended

                 
   

March 31,

   

Change

 
   

2025

   

2024

   

Amount

   

%

 
   

(in thousands, except percentages)

 

Research and development

  $ 12,689     $ 10,486     $ 2,203       21.0 %

Percentage of revenue

    13.6 %     14.1 %            
                                 

GAAP research and development

  $ 12,689     $ 10,486     $ 2,203       21.0 %

Stock-based compensation expense

    (2,198 )     (1,336 )     (862 )     64.5 %

Non-GAAP research and development

  $ 10,491     $ 9,150     $ 1,341       14.7 %

Non-GAAP percentage of revenue

    11.3 %     12.3 %            

 

Research and development expenses  increased   21.0%  to $12.7  million for the three months ended March 31, 2025 , primarily driven by a $1.9 million increase in personnel costs associated with the expansion of our workforce.

 

Income Tax Provision

 

Income tax expense during the three months ended March 31, 2025 and 2024 was as follows:

 

   

Three Months Ended

                 
   

March 31,

   

Change

 
   

2025

   

2024

   

Amount

   

%

 
   

(in thousands, except percentages)

 

Income tax expense

  $ 1,307     $ 2,157     $ (850 )     (39.4 )%

 

AvePoint’s income tax expense for the three months ended March 31, 2025 was $1.3 million, as compared to a tax expense of $2.2 million for the three months ended March 31, 2024. The effective tax rate was 26.8% for the three months ended March 31, 2025, compared to 1062.6% for the three months ended March 31, 2024. The change in effective tax rates was primarily due to the mix of pre-tax income (loss) results by jurisdictions taxed at different rates, certain jurisdictions with separate tax expense calculated, impact of foreign inclusions, stock-based compensation, and changes in valuation allowance.

 

In assessing the need for a valuation allowance, the Company has considered all available positive and negative evidence including its historical levels of income, expectations of future taxable income, future reversals of existing taxable temporary differences and ongoing tax planning strategies. If in the future, the Company determines it is more likely than not that deferred tax assets will not be realized, the Company may set up a valuation allowance, which may result in income tax expense in the Company’s condensed consolidated statements of income (loss) and condensed consolidated statements of comprehensive income (loss).

 

37

Part I
Item 2

 

Non-GAAP Operating Income and Non-GAAP Operating Margin

 

The following table presents a reconciliation of non-GAAP operating income from the most comparable GAAP measure, operating income, for the periods presented:

 

   

Three Months Ended

 
   

March 31,

 
   

2025

   

2024

 
   

(in thousands, except percentages)

 

GAAP operating income (loss)

  $ 3,287     $ (3,201 )

GAAP operating margin

    3.5 %     (4.3 )%

Add:

               

Stock-based compensation

    9,620       9,458  

Amortization of acquired intangible assets

    466       353  

Non-GAAP operating income

  $ 13,373     $ 6,610  

Non-GAAP operating margin

    14.4 %     8.9 %

 

Non-GAAP operating income and non-GAAP operating margin are non-GAAP financial measures that our management uses to assess our overall performance. We define non-GAAP operating income as GAAP operating income (loss) plus stock-based compensation and the amortization of acquired intangible assets. We define non-GAAP operating margin as non-GAAP operating income divided by revenue. We believe non-GAAP operating income and non-GAAP operating margin provide our management and investors consistency and comparability with our past financial performance and facilitate period-to-period comparisons of operations, as these metrics eliminate the effects of stock-based compensation, which has had historical volatility from period to period due to mark-to-market securities, and of acquired intangible assets, which are unrelated to current operations and are neither comparable to the prior period nor predictive of future results. The elimination of the effect of variability caused by stock-based compensation expense and the amortization of acquired intangible assets, both of which are non-cash expenses, provides a better representation as to the overall operating performance of the Company. We use non-GAAP financial measures (a) to evaluate our historical and prospective financial performance and trends as well as our performance relative to our peers, (b) to set and approve spending budgets, (c) to allocate resources, (d) to measure operational profitability and the accuracy of forecasting, and (e) to assess financial discipline over operational expenditures.

 

GAAP operating margin for the three months ended March 31, 2025 and 2024 was 3.5% and (4.3)%, respectively. Non-GAAP operating margin for the three months ended March 31, 2025 and 2024 was 14.4% and 8.9%, respectively. The increase in non-GAAP operating margin was primarily attributable to the Company’s enhanced focus on expense management and continued scaling of the Company’s channel partner strategy.

 

Liquidity and Capital Resources

 

As of March 31, 2025, we had $351.5 million in cash and cash equivalents and $0.3 million in short-term investments and no outstanding debt.

 

Our short-term liquidity needs primarily include working capital for sales and marketing, research and development, and continued innovation. In addition, we extended a credit facility with a remaining commitment of $1.5 million, and committed $50.0 million to a growth equity fund. We also have letters of credit issued in the amount of $1.0 million as security for operating leases, and $4.8 million as security for customer contingency agreements. Our long-term capital requirements will depend on many factors, including our growth rate, levels of revenue, the expansion of sales and marketing activities, market acceptance of our platform, the results of business initiatives, and the timing of new product introductions. See “Note 10 Commitments and Contingencies” in Part I, Item 1 “Financial Statements” of this Quarterly Report on Form 10-Q for more information regarding the purchase commitments.

 

38

Part I
Item 2

 

We also maintain a loan and security agreement (the “Loan Agreement”), dated November 3, 2023, with HSBC Bank USA, National Association, (“HSBC”), as lender, for a revolving line of credit of up to $30.0 million with an accordion feature that provides up to $20.0 million of additional borrowing capacity we may draw upon at our request. The line bears interest at a rate equal to term SOFR plus 3.0% to 3.3% depending on the Consolidated Total Leverage Ratio (as defined in the Loan Agreement). The line carries an unused fee equal to 0.5%. The line will mature on November 3, 2026. We are required to maintain a minimum Consolidated Fixed Charge Coverage Ratio (as defined in the Loan Agreement) as well as a maximum Consolidated Total Leverage Ratio, tested by HSBC each quarter. Pursuant to the Loan Agreement, we pledged, assigned and granted HSBC a security interest in all shares of our subsidiaries, future proceeds, and assets as security for our obligations under the Loan Agreement. As of March 31, 2025, we are compliant with all covenants and had no borrowings outstanding under the Loan Agreement.

 

We believe that our existing cash and cash equivalents, our cash flows from operating activities, and our borrowing capacity under our Loan Agreement will be sufficient to meet our working capital and capital expenditure needs for at least the next twelve months. In the future, we may attempt to raise additional capital through equity or debt financing. The sale of additional equity would be dilutive to our stockholders. Additional debt financing could result in increased debt service obligations and more restrictive financial and operational covenants.

 

Cash Flows

 

The following table sets forth a summary of AvePoint’s cash flows for the periods indicated.

 

   

Three Months Ended

 
   

March 31,

 
   

2025

   

2024

 
    (in thousands)  

Net cash provided by operating activities

  $ 495     $ 7,756  

Net cash used in investing activities

    (16,859 )     (1,542 )

Net cash provided by (used in) financing activities

    76,181       (12,961 )

 

Operating Activities

 

Net cash provided by operating activities for the three months ended March 31, 2025 was $0.5 million, reflecting AvePoint’s net income of $3.6 million, adjusted for non-cash items of $14.0 million and net cash outflows of $17.1 million from changes in operating assets and liabilities. The primary drivers of non-cash items were stock-based compensation which reflects ongoing compensation and offset by a decrease in the mark to market value of warranty liabilities. The drivers of changes in operating assets and liabilities are seasonal in nature. These drivers are related to a decrease in accounts receivable due primarily to the timing of customer invoices and a decrease in prepaid expenses and other current assets primarily related to prepaid rent, an increase in deferred revenue, offset by a decrease in accrued expenses primarily due to accrued bonuses, commissions and payroll taxes.

 

Net cash provided by operating activities for the three months ended March 31, 2024 was $7.8 million, reflecting AvePoint’s net loss of $2.0 million, adjusted for non-cash items of $11.0 million and net cash outflows of $1.3 million from changes in operating assets and liabilities. The primary drivers of non-cash items were stock-based compensation which reflects ongoing compensation and an increase in the mark to market value of earn-out and warranty liabilities. The drivers of changes in operating assets and liabilities are seasonal in nature. These drivers are related to a decrease in accounts receivable due primarily to timing of customer invoices and decrease in prepaid expenses and other current assets primarily related to prepaid insurance, an increase in deferred revenue and a decrease in accrued expenses primarily due to accrued bonuses, commissions and VAT/sales tax payable.

 

Investing Activities

 

Net cash used in investing activities for the three months ended March 31, 2025 was $16.9 million. It primarily consisted of $14.9 million cash paid in business acquisitions, $1.5 million of purchases of property and equipment, and $0.5 million from the capitalization of internal use software.

 

Net cash used in investing activities for the three months ended March 31, 2024 was $1.5 million. It primarily consisted of $0.5 million of purchases of property and equipment, $0.4 million of purchases of short-term investments, and $0.4 million from the capitalization of internal use software, partially offset by $0.2 million from the maturity of short-term investments.

 

39

Part I
Item 2

 

Financing Activities

 

Net cash provided by financing activities for the three months ended March 31, 2025 was $76.2 million, primarily consisting of $87.3 million of proceeds from the exercises of warrants and $0.7 million of proceeds from the exercise of stock options, partially offset by $11.8 million in repurchases of common stock under the previously announced Share Repurchase Program that authorizes us to repurchase up to $150 million of our common shares (the “Share Repurchase Program”).

 

Net cash used in financing activities for the three months ended March 31, 2024 was $13.0 million, primarily consisting of $13.7 million in repurchases of common stock under the Share Repurchase Program, partially offset by $0.8 million of proceeds from the exercise of stock options.

 

Indebtedness

 

Credit Facility

 

We maintain a line of credit under the Loan Agreement with HSBC, as lender. See “Note 7 - Line of Credit” in Part I, Item 1 “Financial Statements” of this Quarterly Report on Form 10-Q.

 

The Loan Agreement provides for a revolving line of credit of up to $30.0 million and an additional $20.0 million accordion feature for additional capital we may draw upon at our request. Borrowings under the line currently bear interest at a rate equal to term SOFR plus 3.0% to 3.3% depending on the Consolidated Total Leverage Ratio (as defined in the Loan Agreement). The line carries an unused fee at a rate equal to 0.5%. Any proceeds of borrowings under the Loan Agreement will be used for general corporate purposes.

 

On a consolidated basis with our subsidiaries, we are required to maintain a minimum Consolidated Fixed Charge Coverage Ratio as well as a maximum Consolidated Total Leverage Ratio, tested by HSBC each quarter. Pursuant to the Loan Agreement, we pledged, assigned, and granted HSBC a security interest in all shares of our subsidiaries, future proceeds, and certain assets as security for our obligations under the Loan Agreement. Our line of credit under the Loan Agreement will mature on November 3, 2026.

 

To date, we are in compliance with all covenants under the Loan Agreement. We have not at any time borrowed under the Loan Agreement. The description of the Loan Agreement is qualified in its entirety by the full text of the form of such agreement, a copy of which is referenced as an exhibit to our Annual Report.

 

Leasing Activities

 

We are obligated under various non-cancelable operating leases for office space. The initial terms of the leases expire on various dates through 2030. As of March 31, 2025, the commitments related to these operating leases is $19.7 million, of which $7.5 million is due in the next twelve months.

 

Operating Segment Information

 

We operate in one segment. Our products and services are sold throughout the world, through direct and indirect sales channels. Our chief operating decision maker (the “CODM”) is our Chief Executive Officer. The CODM makes operating performance assessment and resource allocation decisions on a global basis. The CODM does not receive discrete financial information about asset allocation or profitability by product or geography. See the section titled “Notes to Condensed Consolidated Financial Statements” (Part I, Item 1 of this Quarterly Report) under the sub-heading “Note 16  Segment Information” for more information.

 

40

Part I
Item 2

 

Critical Accounting Policies and Estimates

 

Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities. We also make estimates and assumptions on the reported revenue generated and reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that our management believes are reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

 

While our significant accounting policies are described in more detail in the section titled “Notes to Condensed Consolidated Financial Statements” (Part I, Item 1 of this Quarterly Report), we believe the following critical accounting policies and estimates are most important to understanding and evaluating our reported financial results.

 

Revenue Recognition

 

We derive revenue from four primary sources: SaaS, term license and support, services, and maintenance. Many of our contracts with customers include multiple performance obligations. Judgement is required in determining whether each performance obligation is distinct. Our products and services generally do not require a significant amount of integration or interdependency; therefore, our products and services are generally not combined. We allocate the transaction price for each contract to each performance obligation based on the relative standalone selling price (“SSP”) for each performance obligation within each contract.

 

We use judgment in determining the SSP for products and services. For substantially all performance obligations except term licenses, we are able to establish the SSP based on the observable prices of products or services sold separately in comparable circumstances to similar customers. We typically establish an SSP range for our products and services which is reassessed on a periodic basis or when facts and circumstances change. Term licenses are sold only as a bundled arrangement that includes the rights to a term license and support. In determining the SSP of license and support in a term license arrangement, we utilize observable inputs and consider the value relationship between support and term license when compared to the value relationship between support and perpetual licenses, the average economic life of our products, and software renewals rates. Using a combination of the relative fair value method, or the residual value method the SSP of the performance obligations in an arrangement is allocated to each performance obligation within a sales arrangement.

 

 

41

Part I
Item 2

 

Economic Conditions, Challenges, and Risks

 

The markets for software and cloud-based services are dynamic and highly competitive. Our competitors are developing new software while also deploying competing cloud-based services for consumers and businesses. Customer preferences evolve rapidly, and choices in hardware, products, and devices can and do influence how users access services in the cloud, and in some cases, the user’s choice of which suite of cloud-based services to use. We must continue to evolve and adapt to keep pace with this changing environment. The investments we are making in infrastructure, research and development, marketing, and geographic expansion will continue to increase our operating costs and may decrease our operating margins.

 

Our success is highly dependent on our ability to attract and retain qualified employees. We hire a mix of university and industry talent worldwide. We compete for talented individuals globally by offering an exceptional working environment, broad customer reach, scale in resources, the ability to grow one’s career across many different products and businesses, and competitive compensation and benefits.

 

Additionally, the demand for our software and services is correlated to global macroeconomic and geopolitical factors, which remain dynamic and where the outcomes and consequences are not possible to predict, and could materially adversely affect global trade, currency exchange rates, regional economies and the global economy. These in turn could increase our costs, disrupt our supply chain, reduce our sales and earnings, impair our ability to raise additional capital when needed on acceptable terms, if at all, or otherwise adversely affect our business, financial condition, and results of operations.

 

Our international operations provide a significant portion of our total revenues and expenses. Many of these revenues and expenses are denominated in currencies other than the U.S. dollar. As a result, changes in foreign exchange rates may significantly affect revenue and expenses. Refer to the section titled “Risk Factors” (Part I, Item 1A of our Annual Report) for a discussion of these factors and other risks.

 

Seasonality

 

Our quarterly revenue fluctuates and does not necessarily grow sequentially when measuring any one fiscal quarter’s revenue against another. Historically, our first quarter has been our lowest revenue quarter and the fourth quarter has been our highest revenue quarter, however those results are not necessarily indicative of future quarterly revenue or full year results. Additionally, the timing of new product and service introductions can significantly impact revenue. Lastly, the mix of revenues in any given quarter can cause fluctuations in our reported results, due to differing revenue recognition principles.

 

Recently Issued and Adopted Accounting Pronouncements

 

For information about recent accounting pronouncements, see “Note 2 - Summary of Significant Accounting Policies” in Part I, Item 1 “Financial Statements” of this Quarterly Report on Form 10-Q.

 

42

Part I

Item 3

 

Item 3. Quantitative and Qualitative Disclosures About Market Risks

 

Interest Rate Risk

 

We had cash and cash equivalents, marketable securities, and short-term deposits of $351.8 million as of March 31, 2025, which we hold for working capital purposes. Our cash and cash equivalents are held in cash deposits and money market funds. Due to the short-term nature of these instruments, we do not believe that we have any material exposure to changes in the fair value of our investment portfolio due to changes in interest rates. Declines in interest rates, however, would reduce our future interest income. The effect of a hypothetical 10% change in interest rates would not have a material negative impact on our condensed consolidated financial statements. As of March 31, 2025, we had no outstanding obligations under our line of credit with HSBC under the Loan Agreement. To the extent we enter into other long-term debt arrangements in the future, we would be subject to fluctuations in interest rates which could have a material impact on our future financial condition and results of operation.

 

Foreign Currency Exchange Risk

 

Fluctuations in foreign currencies impact the amount of total assets and liabilities that we report for our foreign subsidiaries upon the translation of these amounts into U.S. Dollars. In particular, the amount of cash, cash equivalents and marketable securities that we report in U.S. Dollars for a significant portion of the cash held by these subsidiaries is subject to translation variance caused by changes in foreign currency exchange rates as of the end of each respective reporting period, the offset to which is substantially recorded to accumulated other comprehensive income on our condensed consolidated balance sheets and is also presented as a line item in its condensed consolidated statements of comprehensive income (loss). We believe we are in large part naturally hedged against foreign currency exchange risk from our ongoing business operations, as most of our regional revenues are generated in the same currency as that region’s expenses are paid. The effect of a hypothetical 10% change in foreign currency exchange rates would not have a material negative impact on our condensed consolidated financial statements.

 

Concentration of Credit Risk

 

We deposit our cash with financial institutions, and, at times, such balances may exceed federally insured limits.

 

43

Part I

Item 4

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer (in his capacity as “Principal Executive Officer”) and our Chief Financial Officer (in his capacity as “Principal Financial and Accounting Officer”), we conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e)) under the Exchange Act, as of the end of the period covered by this Quarterly Report. Based upon that evaluation, our Principal Executive Officer and Principal Financial and Accounting Officer concluded that our disclosure controls and procedures were effective as of March 31, 2025.

 

As such, our Principal Executive Officer and Principal Financial and Accounting Officer have concluded that our condensed consolidated financial statements included in this report present fairly, in all material respects, our financial position, results of operations, and cash flows for the periods presented in conformity with U.S. generally accepted accounting principles (“GAAP”).

 

Changes in Internal Control Over Financial Reporting

 

There have been no changes in our internal control over financial reporting during the quarter ended March 31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

 

44

Part II

Items 1 and 1A

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

In the normal course of our business, we may be involved in various claims, negotiations, and legal actions. Except for such claims that arise in the normal course of business, as of and for the fiscal quarter ended March 31, 2025, we are not a party to any material asserted, ongoing, threatened, or pending claims, suits, assessments, proceedings, or other litigation.

 

Refer to the information under the section titled “Risk Factors” of our Annual Report (Part I, Item 1A of our Annual Report) for information regarding the potential legal and regulatory risks (including potential legal proceedings and litigation) in which we may become involved.

 

Item 1A. Risk Factors

 

Our operations and financial results are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” in our Annual Report, which risks and uncertainties could affect our business, financial condition, results of operations, cash flows, and the trading price of our common stock. Other than the risk factor set below, there have been no material changes to the risk factors previously disclosed in our Annual Report. We urge you to read the risk factors in our Annual Report.

 

International trade policies, including tariffs, sanctions and trade barriers may adversely affect our business, financial condition, results of operations and prospects.

 

In recent months, markets, businesses and consumers have reacted adversely to volatility and uncertainty in international trade policies. Among other things, significant and new tariffs, sanctions and trade barriers have been imposed and modified, impacting a broad range of raw materials, goods and international trade more generally. Although our current business model is not directly reliant on the import or export of physical goods, tariffs or other trade policies may indirectly adversely impact our business. For example, any future tariffs on software as a service could make our products more expensive, decrease our profitability or lessen demand for our products.  Additionally, any of our customers affected by current or future tariffs may find themselves in an expense-reducing environment and not renew or reduce a contract with us upon renewal.

 

While we continue to monitor trade developments, the ultimate impact of these risks remains uncertain and any prolonged economic downturn, escalation in trade tensions, or deterioration in international perception of U.S.-based companies could materially and adversely affect our business, financial condition, results of operations and prospects. 

 

45

Part II

Items 2, 3 and 4

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES

 

During the quarter ended March 31, 2025, we did not issue any shares of our common stock or any other equity securities without registration under the Securities Act of 1933, as amended.

 

Issuer Purchases of Equity Securities.

 

On March 17, 2022, we announced that our Board of Directors authorized the Share Repurchase Program for us to buy back shares of our common stock for a period of three years from the date of authorization. On February 25, 2025, the Company’s Board of Directors renewed the Share Repurchase Program for an additional three years from the date of renewal. Under the Share Repurchase Program, we have the authority to buy up to $150 million of our common stock shares via acquisitions in the open market or privately negotiated transactions. Purchases made pursuant to the Share Repurchase Program may be conducted in compliance with Exchange Act Rule 10b-18 and/or Exchange Act Rule 10b5-1. Purchases made pursuant to the Share Repurchase Program will be conducted in compliance with all applicable legal, regulatory, and internal policy requirements, including our Insider Trading Policy. We are not obligated to make purchases of, nor are we obligated to acquire any particular amount of, our common stock under the Share Repurchase Program. The Share Repurchase Program may be suspended or discontinued at any time.

 

The following table presents information with respect to common stock shares repurchased under the Share Repurchase Program during the three months ended March 31, 2025:

 

Period

Total number of shares purchased(1)

Average price paid per share(2)

Total number of shares purchased as part of the Share Repurchase Program

Approximate dollar value of shares that may yet be purchased under the Share Repurchase Program(3)

January 1, 2025 - January 31, 2025

3,093

$16.5426

3,093

$57,932,353

February 1, 2025 - February 28, 2025

11,674

$19.0935

11,674

$57,709,455

March 1, 2025 - March 31, 2025

786,228

$14.7939

786,228

$138,368,600

 

(1) All shares reported herein, including shares repurchased to satisfy employee taxes on vesting RSUs, were purchased pursuant to the publicly announced Share Repurchase Program.

(2) Average price paid per share includes costs associated with the repurchases and excludes the 1% excise tax on stock repurchases enacted by the Inflation Reduction Act of 2022.

(3) The maximum remaining dollar value of shares that may yet be purchased under the Share Repurchase Program is reduced by the aggregate price paid for share purchases in addition to any fees, commissions, or other costs that may arise as a result of the purchase.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

46

Part II

Item 5

 

 

ITEM 5. OTHER INFORMATION

 

Rule 10b5-1 Plan Election 

 

On December 18, 2024, Brian Michael Brown, our Chief Legal and Compliance Officer, and Secretary, adopted a Rule 10b5-1 trading arrangement, as defined in Item 408 of Regulation S-K, providing for the sale from time to time of an aggregate of up to 240,000 shares of common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until December 18, 2025, or earlier if all transactions under the trading arrangement are completed.

 

Subsequent Events

 

The following material subsequent event occurred since the date of the most recent balance sheet period reported.

 

At the end of March 2025, the Company offered to purchase all of the remaining outstanding interest of MaivenPoint from the remaining minority interest holders for an aggregate total of approximately $11.6 million in cash. As of the end of April, all minority interest holders accepted the Company’s offer subject to acceptable terms and conditions to be drafted in a shareholder purchase agreement in May 2025.  Following the acquisition of the interest, the Company will be the sole interest holder in MaivenPoint.

 

 

 

47

Part II

Item 6

 

Item 6. Exhibits

 

The following exhibits are filed as part of, furnished with, or incorporated by reference into, this Quarterly Report on Form 10-Q, in each case as indicated therein.

 

Exhibit Index

 

       

Incorporated by Reference

Exhibit
Number

 

Description

 

Schedule/

Form

 

File No.

 

Exhibit

 

Filing Date

  Filed Herewith

31.1

 
                  X

31.2

 

Certification of Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

                  X

32.1**

 

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

                  X

32.2**

 

Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

                  X

101.INS

 

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

                  X

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document.

                  X

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

                  X

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document.

                  X

101.LAB

 

Inline XBRL Taxonomy Extension Labels Linkbase Document.

                  X

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

                  X

104.1

 

Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit 101).

                  X

 

**

Furnished herewith. Any exhibit furnished herewith (including the certifications furnished in Exhibit 32.1 and Exhibit 32.2 hereto) are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.

 

48

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  AVEPOINT, INC.
   

Date: May 8, 2025

/s/ Tianyi Jiang

 

Name:

Tianyi Jiang

 

Title:

Chief Executive Officer

(Principal Executive Officer)

 

Date: May 8, 2025

/s/ James Caci

 

Name:

James Caci

 

Title:

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

49

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15(D)-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15(D)-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.

XBRL TAXONOMY EXTENSION SCHEMA

XBRL TAXONOMY EXTENSION CALCULATION LINKBASE

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE

XBRL TAXONOMY EXTENSION LABEL LINKBASE

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: R42.htm

IDEA: R43.htm

IDEA: R44.htm

IDEA: R45.htm

IDEA: R46.htm

IDEA: R47.htm

IDEA: R48.htm

IDEA: R49.htm

IDEA: R50.htm

IDEA: R51.htm

IDEA: R52.htm

IDEA: R53.htm

IDEA: R54.htm

IDEA: R55.htm

IDEA: R56.htm

IDEA: R57.htm

IDEA: R58.htm

IDEA: R59.htm

IDEA: R60.htm

IDEA: R61.htm

IDEA: R62.htm

IDEA: R63.htm

IDEA: R64.htm

IDEA: R65.htm

IDEA: R66.htm

IDEA: R67.htm

IDEA: R68.htm

IDEA: R69.htm

IDEA: R70.htm

IDEA: R71.htm

IDEA: R72.htm

IDEA: Financial_Report.xlsx

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: avpt20250331_10q_htm.xml